BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, Blumberg RS, Serhan CN. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA. 2005;102:7671-7676. [PMID: 15890784 DOI: 10.1073/pnas.0409271102] [Cited by in Crossref: 433] [Cited by in F6Publishing: 399] [Article Influence: 25.5] [Reference Citation Analysis]
Number Citing Articles
1 Nagaishi T, Iijima H, Nakajima A, Chen D, Blumberg RS. Role of CEACAM1 as a Regulator of T Cells. Annals of the New York Academy of Sciences 2006;1072:155-75. [DOI: 10.1196/annals.1326.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
2 Kong W, Yen JH, Ganea D. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav Immun 2011;25:872-82. [PMID: 20854895 DOI: 10.1016/j.bbi.2010.09.012] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
3 Rius B, López-Vicario C, González-Périz A, Morán-Salvador E, García-Alonso V, Clária J, Titos E. Resolution of inflammation in obesity-induced liver disease. Front Immunol 2012;3:257. [PMID: 22934096 DOI: 10.3389/fimmu.2012.00257] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
4 Stapleton RD, Martin JM, Mayer K. Fish oil in critical illness: mechanisms and clinical applications. Crit Care Clin 2010;26:501-14, ix. [PMID: 20643303 DOI: 10.1016/j.ccc.2010.04.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
5 Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res. 2012;51:232-237. [PMID: 22542696 DOI: 10.1016/j.plipres.2012.02.003] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 10.0] [Reference Citation Analysis]
6 Kholy KE, Genco RJ, Van Dyke TE. Oral infections and cardiovascular disease. Trends in Endocrinology & Metabolism 2015;26:315-21. [DOI: 10.1016/j.tem.2015.03.001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 14.9] [Reference Citation Analysis]
7 Chee B, Park B, Fitzsimmons T, Coates AM, Bartold PM. Omega-3 fatty acids as an adjunct for periodontal therapy-a review. Clin Oral Investig 2016;20:879-94. [PMID: 26885664 DOI: 10.1007/s00784-016-1750-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
8 Avila-Román J, Talero E, Alcaide A, Reyes Cde L, Zubía E, García-Mauriño S, Motilva V. Preventive effect of the microalga Chlamydomonas debaryana on the acute phase of experimental colitis in rats. Br J Nutr 2014;112:1055-64. [PMID: 25192306 DOI: 10.1017/S0007114514001895] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, Pot B, Simonet M, Daniel C. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology. 2007;133:862-874. [PMID: 17678918 DOI: 10.1053/j.gastro.2007.06.018] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 5.5] [Reference Citation Analysis]
10 Chiu CY, Gomolka B, Dierkes C, Huang NR, Schroeder M, Purschke M, Manstein D, Dangi B, Weylandt KH. Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflamm Res. 2012;61:967-976. [PMID: 22618200 DOI: 10.1007/s00011-012-0489-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
11 Small M, Serhan CN, Libreros S, Nshimiyimana R. E-series Resolvin Metabolome, Biosynthesis and Critical Role of Stereochemistry of Specialized Pro-Resolving Mediators (SPMs) in Inflammation-Resolution: Preparing SPMs for Long COVID-19, Human Clinical Trials, and Targeted Precision Nutrition. Seminars in Immunology 2022. [DOI: 10.1016/j.smim.2022.101597] [Reference Citation Analysis]
12 Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review. Life Sci 2018;203:255-67. [PMID: 29715470 DOI: 10.1016/j.lfs.2018.04.049] [Cited by in Crossref: 285] [Cited by in F6Publishing: 210] [Article Influence: 71.3] [Reference Citation Analysis]
13 Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007;101:577-599. [PMID: 17257165 DOI: 10.1111/j.1471-4159.2006.04371.x] [Cited by in Crossref: 309] [Cited by in F6Publishing: 238] [Article Influence: 20.6] [Reference Citation Analysis]
14 Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 2010;107:1170-84. [PMID: 21071715 DOI: 10.1161/CIRCRESAHA.110.223883] [Cited by in Crossref: 266] [Cited by in F6Publishing: 133] [Article Influence: 22.2] [Reference Citation Analysis]
15 Calder PC. Fatty acids and immune function: relevance to inflammatory bowel diseases. Int Rev Immunol 2009;28:506-34. [PMID: 19954361 DOI: 10.3109/08830180903197480] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
16 Gao L, Faibish D, Fredman G, Herrera BS, Chiang N, Serhan CN, Van Dyke TE, Gyurko R. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol 2013;190:689-94. [PMID: 23241890 DOI: 10.4049/jimmunol.1103688] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 7.3] [Reference Citation Analysis]
17 Mao Y, Ren J, Li J. Regulated spatial distribution of cyclooxygenases and lipoxygenases in Crohn's ulcer. Mediators Inflamm 2006;2006:89581. [PMID: 16951496 DOI: 10.1155/MI/2006/89581] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Vartak T, Godson C, Brennan E. Therapeutic potential of pro-resolving mediators in diabetic kidney disease. Adv Drug Deliv Rev 2021;178:113965. [PMID: 34508793 DOI: 10.1016/j.addr.2021.113965] [Reference Citation Analysis]
19 Hong S, Lu Y. Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury. Front Immunol 2013;4:13. [PMID: 23386851 DOI: 10.3389/fimmu.2013.00013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
20 Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012;5:354-66. [DOI: 10.1038/mi.2012.24] [Cited by in Crossref: 320] [Cited by in F6Publishing: 311] [Article Influence: 32.0] [Reference Citation Analysis]
21 Bennett M, Gilroy DW. Lipid Mediators in Inflammation. Microbiol Spectr 2016;4. [PMID: 27837747 DOI: 10.1128/microbiolspec.MCHD-0035-2016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
22 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225] [Cited by in Crossref: 1228] [Cited by in F6Publishing: 1209] [Article Influence: 102.3] [Reference Citation Analysis]
23 Parian AM, Limketkai BN, Shah ND, Mullin GE. Nutraceutical Supplements for Inflammatory Bowel Disease. Nutr Clin Pract. 2015;30:551-558. [PMID: 26024677 DOI: 10.1177/0884533615586598] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
24 Camba-Gómez M, Gualillo O, Conde-Aranda J. New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation. Int J Mol Sci 2021;22:2605. [PMID: 33807591 DOI: 10.3390/ijms22052605] [Reference Citation Analysis]
25 Campbell EL, Serhan CN, Colgan SP. Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators. J Immunol 2011;187:3475-81. [PMID: 21934099 DOI: 10.4049/jimmunol.1100150] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
26 Edwards JM, McCarthy CG, Wenceslau CF. The Obligatory Role of the Acetylcholine-Induced Endothelium-Dependent Contraction in Hypertension: Can Arachidonic Acid Resolve this Inflammation? Curr Pharm Des 2020;26:3723-32. [PMID: 32303165 DOI: 10.2174/1381612826666200417150121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
27 Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1-17. [PMID: 18297430 DOI: 10.1007/s00535-007-2111-3] [Cited by in Crossref: 116] [Cited by in F6Publishing: 116] [Article Influence: 8.3] [Reference Citation Analysis]
28 Cox R Jr, Phillips O, Fukumoto J, Fukumoto I, Parthasarathy PT, Arias S, Cho Y, Lockey RF, Kolliputi N. Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment. Am J Respir Cell Mol Biol 2015;53:422-35. [PMID: 25647402 DOI: 10.1165/rcmb.2014-0339OC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
29 Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851:469-484. [PMID: 25149823 DOI: 10.1016/j.bbalip.2014.08.010] [Cited by in Crossref: 754] [Cited by in F6Publishing: 689] [Article Influence: 94.3] [Reference Citation Analysis]
30 Recchiuti A. Resolvin D1 and its GPCRs in resolution circuits of inflammation. Prostaglandins & Other Lipid Mediators 2013;107:64-76. [DOI: 10.1016/j.prostaglandins.2013.02.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
31 Norling LV, Serhan CN. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J Intern Med 2010;268:15-24. [PMID: 20497301 DOI: 10.1111/j.1365-2796.2010.02235.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 31] [Article Influence: 0.7] [Reference Citation Analysis]
32 Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, Bowers BE, Scully M, Bruyninckx WJ, Colgan SP. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proc Natl Acad Sci USA. 2010;107:14298-14303. [PMID: 20660763 DOI: 10.1073/pnas.0914730107] [Cited by in Crossref: 127] [Cited by in F6Publishing: 116] [Article Influence: 10.6] [Reference Citation Analysis]
33 Yazdi PG. A review of the biologic and pharmacologic role of docosapentaenoic acid n-3. F1000Res 2013;2:256. [PMID: 25232466 DOI: 10.12688/f1000research.2-256.v2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
34 Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 2011;437:185-97. [PMID: 21711247 DOI: 10.1042/BJ20110327] [Cited by in Crossref: 99] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
35 Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 Fatty Acid-Derived Mediators 17( R )-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice. J I 2011;187:1957-69. [DOI: 10.4049/jimmunol.1101305] [Cited by in Crossref: 168] [Cited by in F6Publishing: 163] [Article Influence: 15.3] [Reference Citation Analysis]
36 Aoki H, Hisada T, Ishizuka T, Utsugi M, Ono A, Koga Y, Sunaga N, Nakakura T, Okajima F, Dobashi K, Mori M. Protective effect of resolvin E1 on the development of asthmatic airway inflammation. Biochem Biophys Res Commun 2010;400:128-33. [PMID: 20708601 DOI: 10.1016/j.bbrc.2010.08.025] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
37 Carlo T, Levy BD. Chemical mediators and the resolution of airway inflammation. Allergol Int 2008;57:299-305. [PMID: 18946231 DOI: 10.2332/allergolint.08-RAI-0018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids 2007;77:327-35. [DOI: 10.1016/j.plefa.2007.10.015] [Cited by in Crossref: 254] [Cited by in F6Publishing: 227] [Article Influence: 16.9] [Reference Citation Analysis]
39 Odusanwo O, Chinthamani S, McCall A, Duffey ME, Baker OJ. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. Am J Physiol Cell Physiol 2012;302:C1331-45. [PMID: 22237406 DOI: 10.1152/ajpcell.00207.2011] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.9] [Reference Citation Analysis]
40 Iizuka Y, Okuno T, Saeki K, Uozaki H, Okada S, Misaka T, Sato T, Toh H, Fukayama M, Takeda N, Kita Y, Shimizu T, Nakamura M, Yokomizo T. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis. FASEB J 2010;24:4678-90. [PMID: 20667973 DOI: 10.1096/fj.10-165050] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
41 Sculley DV. Periodontal disease: modulation of the inflammatory cascade by dietary n-3 polyunsaturated fatty acids. J Periodont Res 2014;49:277-81. [DOI: 10.1111/jre.12116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
42 Mashima R, Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol 2015;6:297-310. [PMID: 26298204 DOI: 10.1016/j.redox.2015.08.006] [Cited by in Crossref: 140] [Cited by in F6Publishing: 129] [Article Influence: 20.0] [Reference Citation Analysis]
43 Barnig C, Levy BD. Innate immunity is a key factor for the resolution of inflammation in asthma. Eur Respir Rev 2015;24:141-53. [PMID: 25726564 DOI: 10.1183/09059180.00012514] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
44 Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J. 2013;27:2220-2232. [PMID: 23407709 DOI: 10.1096/fj.12-225615] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 8.6] [Reference Citation Analysis]
45 Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51-67. [PMID: 26688348 DOI: 10.1038/nri.2015.4] [Cited by in Crossref: 250] [Cited by in F6Publishing: 239] [Article Influence: 35.7] [Reference Citation Analysis]
46 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Shores DR, Binion DG, Freeman BA, Baker PR. New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. Inflamm Bowel Dis 2011;17:2192-204. [PMID: 21910181 DOI: 10.1002/ibd.21560] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
48 Serhan CN. Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators. Journal of Thrombosis and Haemostasis 2009;7:44-8. [DOI: 10.1111/j.1538-7836.2009.03396.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
49 Shevalye H, Yorek MS, Coppey LJ, Holmes A, Harper MM, Kardon RH, Yorek MA. Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. J Neurophysiol 2015;114:199-208. [PMID: 25925322 DOI: 10.1152/jn.00224.2015] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
50 Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, Capaldo CT, Peatman E, Severson EA, Flower RJ, Perretti M, Parkos CA, Nusrat A. Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 2008;181:5035-44. [PMID: 18802107 DOI: 10.4049/jimmunol.181.7.5035] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
51 Haworth O, Levy BD. Lipoxins, resolvins and protectins: new leads for the treatment of asthma. Expert Opin Drug Discov 2008;3:1209-22. [PMID: 23489078 DOI: 10.1517/17460441.3.10.1209] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
52 An JU, Kim SE, Oh DK. Molecular insights into lipoxygenases for biocatalytic synthesis of diverse lipid mediators. Prog Lipid Res 2021;83:101110. [PMID: 34144023 DOI: 10.1016/j.plipres.2021.101110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Nesman JI, Tungen JE, Vik A, Hansen TV. Stereoselective synthesis of the specialized pro-resolving and anti-inflammatory mediator resolvin E1. Tetrahedron 2020;76:130821. [DOI: 10.1016/j.tet.2019.130821] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Serhan CN. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Prostaglandins Leukot Essent Fatty Acids. 2008;79:157-163. [PMID: 19008087 DOI: 10.1016/j.plefa.2008.09.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
55 Burri L, Hoem N, Banni S, Berge K. Marine omega-3 phospholipids: metabolism and biological activities. Int J Mol Sci. 2012;13:15401-15419. [PMID: 23203133 DOI: 10.3390/ijms131115401] [Cited by in Crossref: 156] [Cited by in F6Publishing: 124] [Article Influence: 15.6] [Reference Citation Analysis]
56 Devassy JG, Leng S, Gabbs M, Monirujjaman M, Aukema HM. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. Adv Nutr 2016;7:905-16. [PMID: 27633106 DOI: 10.3945/an.116.012187] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 9.5] [Reference Citation Analysis]
57 Hajeyah AA, Griffiths WJ, Wang Y, Finch AJ, O'Donnell VB. The Biosynthesis of Enzymatically Oxidized Lipids. Front Endocrinol (Lausanne) 2020;11:591819. [PMID: 33329396 DOI: 10.3389/fendo.2020.591819] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
58 Rama D, Esendagli G, Guc D. Expression of chemokine-like receptor 1 (CMKLR1) on J744A.1 macrophages co-cultured with fibroblast and/or tumor cells: modeling the influence of microenvironment. Cell Immunol 2011;271:134-40. [PMID: 21752353 DOI: 10.1016/j.cellimm.2011.06.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
59 Vassiliou EK, Kesler OM, Tadros JH, Ganea D. Bone Marrow-Derived Dendritic Cells Generated in the Presence of Resolvin E1 Induce Apoptosis of Activated CD4 + T Cells. J Immunol 2008;181:4534-44. [DOI: 10.4049/jimmunol.181.7.4534] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
60 Heo KW, Pak K, Kurabi A, Ryan AF. Leukotriene B4 Is a Major Determinant of Leukocyte Recruitment During Otitis Media. Front Cell Infect Microbiol 2021;11:768815. [PMID: 35004347 DOI: 10.3389/fcimb.2021.768815] [Reference Citation Analysis]
61 te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis. 2006;12:995-999. [PMID: 17012970 DOI: 10.1097/01.mib.0000227817.54969.5e] [Cited by in Crossref: 132] [Cited by in F6Publishing: 138] [Article Influence: 8.8] [Reference Citation Analysis]
62 Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 2008;9:873-9. [PMID: 18568027 DOI: 10.1038/ni.1627] [Cited by in Crossref: 305] [Cited by in F6Publishing: 278] [Article Influence: 21.8] [Reference Citation Analysis]
63 van der Vorst EPC, Peters LJF, Müller M, Gencer S, Yan Y, Weber C, Döring Y. G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis. Front Pharmacol 2019;10:531. [PMID: 31191301 DOI: 10.3389/fphar.2019.00531] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
64 Ungaro F, Tacconi C, Massimino L, Corsetto PA, Correale C, Fonteyne P, Piontini A, Garzarelli V, Calcaterra F, Della Bella S, Spinelli A, Carvello M, Rizzo AM, Vetrano S, Petti L, Fiorino G, Furfaro F, Mavilio D, Maddipati KR, Malesci A, Peyrin-Biroulet L, D'Alessio S, Danese S. MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice. Gastroenterology 2017;153:1363-1377.e6. [PMID: 28827082 DOI: 10.1053/j.gastro.2017.07.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
65 Becker F, Romero E, Goetzmann J, Hasselschwert DL, Dray B, Vanchiere J, Fontenot J, Yun JW, Norris PC, White L, Musso M, Serhan CN, Alexander JS, Gavins FNE. Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys. Am J Pathol 2019;189:1953-72. [PMID: 31547920 DOI: 10.1016/j.ajpath.2019.05.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
66 Patel SJ, Luther J, Bohr S, Iracheta-Vellve A, Li M, King KR, Chung RT, Yarmush ML. A Novel Resolvin-Based Strategy for Limiting Acetaminophen Hepatotoxicity. Clin Transl Gastroenterol 2016;7:e153. [PMID: 26986653 DOI: 10.1038/ctg.2016.13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
67 Levy BD. Resolvins and protectins: natural pharmacophores for resolution biology. Prostaglandins Leukot Essent Fatty Acids 2010;82:327-32. [PMID: 20227865 DOI: 10.1016/j.plefa.2010.02.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
68 Cash JL, White GE, Greaves DR. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol 2009;461:379-96. [PMID: 19480928 DOI: 10.1016/S0076-6879(09)05417-2] [Cited by in Crossref: 80] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
69 Wawrzyniak P, Noureddine N, Wawrzyniak M, Lucchinetti E, Krämer SD, Rogler G, Zaugg M, Hersberger M. Nutritional Lipids and Mucosal Inflammation. Mol Nutr Food Res 2021;65:e1901269. [PMID: 32780927 DOI: 10.1002/mnfr.201901269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Cox R, Phillips O, Fukumoto J, Fukumoto I, Tamarapu Parthasarathy P, Mandry M, Cho Y, Lockey R, Kolliputi N, Koval M. Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine Secretion. PLoS ONE 2015;10:e0136755. [DOI: 10.1371/journal.pone.0136755] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
71 Brodhun F, Feussner I. Oxylipins in fungi. FEBS J 2011;278:1047-63. [PMID: 21281447 DOI: 10.1111/j.1742-4658.2011.08027.x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 116] [Article Influence: 11.8] [Reference Citation Analysis]
72 Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 2014;13:533-48. [PMID: 24948120 DOI: 10.1038/nrd4334] [Cited by in Crossref: 438] [Cited by in F6Publishing: 418] [Article Influence: 54.8] [Reference Citation Analysis]
73 Serhan CN, Chiang N, Dalli J. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Semin Immunol. 2015;27:200-215. [PMID: 25857211 DOI: 10.1016/j.smim.2015.03.004] [Cited by in Crossref: 310] [Cited by in F6Publishing: 283] [Article Influence: 44.3] [Reference Citation Analysis]
74 Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. J Pharmacol Exp Ther. 2010;332:541-548. [PMID: 19846590 DOI: 10.1124/jpet.109.159046] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
75 Marrone MC, Coccurello R. Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases. Biomolecules 2019;10:E12. [PMID: 31861745 DOI: 10.3390/biom10010012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
76 Taguchi A, Yamashita A, Kawana K, Nagamatsu T, Furuya H, Inoue E, Osuga Y, Fujii T. Recent Progress in Therapeutics for Inflammation-Associated Preterm Birth: A Review. Reprod Sci 2016;24:7-18. [DOI: 10.1177/1933719115618282] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
77 Titos E, Clària J. Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation. Prostaglandins Other Lipid Mediat 2013;107:77-84. [PMID: 23707933 DOI: 10.1016/j.prostaglandins.2013.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
78 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
79 Vieira de Barros K, Gomes de Abreu G, Xavier RA, Real Martinez CA, Ribeiro ML, Gambero A, de Oliveira Carvalho P, Silveira VL. Effects of a high fat or a balanced omega 3/omega 6 diet on cytokines levels and DNA damage in experimental colitis. Nutrition 2011;27:221-6. [PMID: 20363597 DOI: 10.1016/j.nut.2009.11.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
80 Colby JK, Jaoude J, Liu F, Shureiqi I. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer. Cancer Metastasis Rev 2018;37:289-315. [DOI: 10.1007/s10555-018-9743-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
81 Westbrook AM, Szakmary A, Schiestl RH. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res. 2010;705:40-59. [PMID: 20298806 DOI: 10.1016/j.mrrev.2010.03.001] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
82 Moreno JJ. Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis. Eur J Pharmacol 2017;796:7-19. [PMID: 27940058 DOI: 10.1016/j.ejphar.2016.12.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
83 Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med 2013;5:661-74. [PMID: 23592557 DOI: 10.1002/emmm.201202382] [Cited by in Crossref: 404] [Cited by in F6Publishing: 376] [Article Influence: 44.9] [Reference Citation Analysis]
84 Sun YB, Qu X, Li X, Nikolic-Paterson DJ, Li J. Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. PLoS One 2013;8:e84063. [PMID: 24391884 DOI: 10.1371/journal.pone.0084063] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
85 Vijay R, Hua X, Meyerholz DK, Miki Y, Yamamoto K, Gelb M, Murakami M, Perlman S. Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection. J Exp Med 2015;212:1851-68. [PMID: 26392224 DOI: 10.1084/jem.20150632] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 9.4] [Reference Citation Analysis]
86 Lee Y, Choo J, Kim SJ, Heo G, Pothoulakis C, Kim YH, Im E. Analysis of endogenous lipids during intestinal wound healing. PLoS One 2017;12:e0183028. [PMID: 28800645 DOI: 10.1371/journal.pone.0183028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
87 Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014;14:166-180. [PMID: 24481336 DOI: 10.1038/nri3607] [Cited by in Crossref: 625] [Cited by in F6Publishing: 618] [Article Influence: 78.1] [Reference Citation Analysis]
88 Dornelles FN, Santos DS, Van Dyke TE, Calixto JB, Batista EL, Campos MM. In Vivo Up-Regulation of Kinin B 1 Receptors after Treatment with Porphyromonas gingivalis Lipopolysaccharide in Rat Paw. J Pharmacol Exp Ther 2009;330:756-63. [DOI: 10.1124/jpet.109.155762] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
89 Natto ZS, Yaghmoor W, Alshaeri HK, Van Dyke TE. Omega-3 Fatty Acids Effects on Inflammatory Biomarkers and Lipid Profiles among Diabetic and Cardiovascular Disease Patients: A Systematic Review and Meta-Analysis. Sci Rep 2019;9:18867. [PMID: 31827125 DOI: 10.1038/s41598-019-54535-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
90 Liu Y, Xiang J, Liu M, Wang S, Lee RJ, Ding H. Protective effects of glycyrrhizic acid by rectal treatment on a TNBS-induced rat colitis model. Journal of Pharmacy and Pharmacology 2011;63:439-46. [DOI: 10.1111/j.2042-7158.2010.01185.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
91 Yan B, Zou Z, Chu H, Chan G, Tsang JO, Lai PM, Yuan S, Yip CC, Yin F, Kao RY, Sze KH, Lau SK, Chan JF, Yuen KY. Lipidomic Profiling Reveals Significant Perturbations of Intracellular Lipid Homeostasis in Enterovirus-Infected Cells. Int J Mol Sci. 2019;20:5952. [PMID: 31779252 DOI: 10.3390/ijms20235952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
92 Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008;367:509-15. [PMID: 18190790 DOI: 10.1016/j.bbrc.2008.01.012] [Cited by in Crossref: 119] [Cited by in F6Publishing: 109] [Article Influence: 8.5] [Reference Citation Analysis]
93 Dutot M, de la Tourrette V, Fagon R, Rat P. New approach to modulate retinal cellular toxic effects of high glucose using marine epa and dha. Nutr Metab (Lond) 2011;8:39. [PMID: 21679392 DOI: 10.1186/1743-7075-8-39] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
94 Serhan CN. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin 2006;24:341-64. [PMID: 16927933 DOI: 10.1016/j.atc.2006.01.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
95 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
96 Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011;111:5922-43. [PMID: 21766791 DOI: 10.1021/cr100396c] [Cited by in Crossref: 607] [Cited by in F6Publishing: 560] [Article Influence: 55.2] [Reference Citation Analysis]
97 Wan Y, Fu Y, Wang F, Sinclair AJ, Li D. Protective Effects of a Lipid Extract from Hard-Shelled Mussel (Mytilus coruscus) on Intestinal Integrity after Lipopolysaccharide Challenge in Mice. Nutrients 2018;10:E860. [PMID: 29970837 DOI: 10.3390/nu10070860] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
98 Demarquoy J, Borgne FL. Biosynthesis, metabolism and function of protectins and resolvins. Clinical Lipidology 2014;9:683-93. [DOI: 10.2217/clp.14.44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
99 Sulijaya B, Takahashi N, Yamazaki K. Host modulation therapy using anti-inflammatory and antioxidant agents in periodontitis: A review to a clinical translation. Arch Oral Biol 2019;105:72-80. [PMID: 31288144 DOI: 10.1016/j.archoralbio.2019.07.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
100 Chang C, Ji Q, Wu B, Yu K, Zeng Q, Xin S, Liu J, Zhou Y. Chemerin15-Ameliorated Cardiac Ischemia-Reperfusion Injury Is Associated with the Induction of Alternatively Activated Macrophages. Mediators Inflamm 2015;2015:563951. [PMID: 26161004 DOI: 10.1155/2015/563951] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
101 Wilson GS, George J. Physical and chemical insults induce inflammation and gastrointestinal cancers. Cancer Lett 2014;345:190-5. [PMID: 23879959 DOI: 10.1016/j.canlet.2013.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
102 Serhan CN, Chiang N. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol. 2008;153 Suppl 1:S200-S215. [PMID: 17965751 DOI: 10.1038/sj.bjp.0707489] [Cited by in Crossref: 217] [Cited by in F6Publishing: 235] [Article Influence: 14.5] [Reference Citation Analysis]
103 Viola J, Soehnlein O. Atherosclerosis - A matter of unresolved inflammation. Semin Immunol 2015;27:184-93. [PMID: 25865626 DOI: 10.1016/j.smim.2015.03.013] [Cited by in Crossref: 129] [Cited by in F6Publishing: 125] [Article Influence: 18.4] [Reference Citation Analysis]
104 Schett G, Neurath MF. Resolution of chronic inflammatory disease: universal and tissue-specific concepts. Nat Commun 2018;9:3261. [PMID: 30111884 DOI: 10.1038/s41467-018-05800-6] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 29.8] [Reference Citation Analysis]
105 Layé S, Nadjar A, Joffre C, Bazinet RP. Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology. Pharmacol Rev 2018;70:12-38. [PMID: 29217656 DOI: 10.1124/pr.117.014092] [Cited by in Crossref: 157] [Cited by in F6Publishing: 129] [Article Influence: 31.4] [Reference Citation Analysis]
106 Dranse HJ, Rourke JL, Stadnyk AW, Sinal CJ. Local chemerin levels are positively associated with DSS-induced colitis but constitutive loss of CMKLR1 does not protect against development of colitis. Physiol Rep 2015;3:e12497. [PMID: 26265756 DOI: 10.14814/phy2.12497] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
107 Titos E, Rius B, González-Périz A, López-Vicario C, Morán-Salvador E, Martínez-Clemente M, Arroyo V, Clària J. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol. 2011;187:5408-5418. [PMID: 22013115 DOI: 10.4049/jimmunol.1100225] [Cited by in Crossref: 278] [Cited by in F6Publishing: 265] [Article Influence: 25.3] [Reference Citation Analysis]
108 Lee CH. Resolvins as new fascinating drug candidates for inflammatory diseases. Arch Pharm Res 2012;35:3-7. [PMID: 22297737 DOI: 10.1007/s12272-012-0121-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
109 Kim KH, Park TS, Kim YS, Lee JS, Oh YM, Lee SD, Lee SW. Resolvin D1 prevents smoking-induced emphysema and promotes lung tissue regeneration. Int J Chron Obstruct Pulmon Dis 2016;11:1119-28. [PMID: 27313451 DOI: 10.2147/COPD.S100198] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
110 Ungaro F, Rubbino F, Danese S, D'Alessio S. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. Front Immunol 2017;8:1331. [PMID: 29109724 DOI: 10.3389/fimmu.2017.01331] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
111 Poorani R, Bhatt AN, Dwarakanath B, Das UN. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance. European Journal of Pharmacology 2016;785:116-32. [DOI: 10.1016/j.ejphar.2015.08.049] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 10.8] [Reference Citation Analysis]
112 Serhan CN, Yacoubian S, Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008;3:279-312. [PMID: 18233953 DOI: 10.1146/annurev.pathmechdis.3.121806.151409] [Cited by in Crossref: 338] [Cited by in F6Publishing: 311] [Article Influence: 24.1] [Reference Citation Analysis]
113 Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885-897. [PMID: 18504706 DOI: 10.1002/mnfr.200700289] [Cited by in Crossref: 293] [Cited by in F6Publishing: 268] [Article Influence: 20.9] [Reference Citation Analysis]
114 Serhan CN, Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 2013;13:632-40. [PMID: 23747022 DOI: 10.1016/j.coph.2013.05.012] [Cited by in Crossref: 201] [Cited by in F6Publishing: 190] [Article Influence: 22.3] [Reference Citation Analysis]
115 Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-361. [PMID: 18437155 DOI: 10.1038/nri2294] [Cited by in Crossref: 1820] [Cited by in F6Publishing: 1699] [Article Influence: 130.0] [Reference Citation Analysis]
116 Serhan CN, Chiang N, Dalli J. Macrophages and the Entrance of Resolution Phase Lipid Mediators. In: Biswas SK, Mantovani A, editors. Macrophages: Biology and Role in the Pathology of Diseases. New York: Springer; 2014. pp. 287-314. [DOI: 10.1007/978-1-4939-1311-4_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med. 2008;205:767-775. [PMID: 18391062 DOI: 10.1084/jem.20071601] [Cited by in Crossref: 240] [Cited by in F6Publishing: 238] [Article Influence: 17.1] [Reference Citation Analysis]
118 Curtis MA, Diaz PI, Van Dyke TE. The role of the microbiota in periodontal disease. Periodontol 2000 2020;83:14-25. [PMID: 32385883 DOI: 10.1111/prd.12296] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 31.5] [Reference Citation Analysis]
119 Sun F, Choi AA, Wu R. Systematic Analysis of Fatty Acids in Human Cells with a Multiplexed Isobaric Tag (TMT)-Based Method. J Proteome Res 2018;17:1606-14. [PMID: 29521506 DOI: 10.1021/acs.jproteome.7b00896] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
120 Weylandt KH, Chiu C, Gomolka B, Waechter SF, Wiedenmann B. Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation. Prostaglandins & Other Lipid Mediators 2012;97:73-82. [DOI: 10.1016/j.prostaglandins.2012.01.005] [Cited by in Crossref: 173] [Cited by in F6Publishing: 156] [Article Influence: 17.3] [Reference Citation Analysis]
121 Jose S, Madan R. Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections. Anaerobe 2016;41:85-90. [PMID: 27063896 DOI: 10.1016/j.anaerobe.2016.04.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
122 Mayer K, Kiessling A, Ott J, Schaefer MB, Hecker M, Henneke I, Schulz R, Günther A, Wang J, Wu L, Roth J, Seeger W, Kang JX. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am J Respir Crit Care Med 2009;179:474-83. [PMID: 19136374 DOI: 10.1164/rccm.200807-1064OC] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
123 Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther 2010;26:431-9. [PMID: 20874497 DOI: 10.1089/jop.2010.0019] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 7.8] [Reference Citation Analysis]
124 Oshima Y, Watanabe T, Endo S, Hata S, Watanabe T, Osada K, Takenaka A. Effects of eicosapentaenoic acid and docosahexaenoic acid on anxiety-like behavior in socially isolated rats. Biosci Biotechnol Biochem 2018;82:716-23. [PMID: 29191085 DOI: 10.1080/09168451.2017.1403888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
125 Quin C, Gibson DL. Dietary Fatty Acids and Host-Microbial Crosstalk in Neonatal Enteric Infection. Nutrients 2019;11:E2064. [PMID: 31484327 DOI: 10.3390/nu11092064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
126 Hamlett ED, Hjorth E, Ledreux A, Gilmore A, Schultzberg M, Granholm AC. RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome. Glia 2020;68:1347-60. [PMID: 31944407 DOI: 10.1002/glia.23779] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
127 Zhang F, Yang H, Pan Z, Wang Z, Wolosin JM, Gjorstrup P, Reinach PS. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci 2010;51:5601-9. [PMID: 20538990 DOI: 10.1167/iovs.09-4468] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
128 Parian AM, Mullin GE, Langhorst J, Brown AC. Inflammatory Bowel Disease. Integrative Medicine. Elsevier; 2018. pp. 501-516.e8. [DOI: 10.1016/b978-0-323-35868-2.00050-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
129 Chromik AM, Müller AM, Albrecht M, Rottmann S, Otte JM, Herdegen T, Uhl W, Mittelkötter U. Oral administration of taurolidine ameliorates chronic DSS colitis in mice. J Invest Surg 2007;20:273-82. [PMID: 17972215 DOI: 10.1080/08941930701598784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
130 Marion-letellier R, Savoye G, Ghosh S. Polyunsaturated fatty acids and inflammation: PUFA and Inflammation. IUBMB Life 2015;67:659-67. [DOI: 10.1002/iub.1428] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 11.4] [Reference Citation Analysis]
131 Buechler C, Pohl R, Aslanidis C. Pro-Resolving Molecules-New Approaches to Treat Sepsis? Int J Mol Sci 2017;18:E476. [PMID: 28241480 DOI: 10.3390/ijms18030476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
132 Vong L, Ferraz JG, Panaccione R, Beck PL, Wallace JL. A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci USA. 2010;107:12023-12027. [PMID: 20547854 DOI: 10.1073/pnas.1004982107] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
133 Keinan D, Leigh NJ, Nelson JW, De Oleo L, Baker OJ. Understanding resolvin signaling pathways to improve oral health. Int J Mol Sci 2013;14:5501-18. [PMID: 23528855 DOI: 10.3390/ijms14035501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
134 Arita M, Clish CB, Serhan CN. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: Novel oxygenase products from ω-3 polyunsaturated fatty acids. Biochemical and Biophysical Research Communications 2005;338:149-57. [DOI: 10.1016/j.bbrc.2005.07.181] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 5.4] [Reference Citation Analysis]
135 Ott J, Hiesgen C, Mayer K. Lipids in critical care medicine. Prostaglandins Leukot Essent Fatty Acids 2011;85:267-73. [PMID: 21546231 DOI: 10.1016/j.plefa.2011.04.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
136 Tjonahen E, Oh SF, Siegelman J, Elangovan S, Percarpio KB, Hong S, Arita M, Serhan CN. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem Biol. 2006;13:1193-1202. [PMID: 17114001 DOI: 10.1016/j.chembiol.2006.09.011] [Cited by in Crossref: 165] [Cited by in F6Publishing: 147] [Article Influence: 11.0] [Reference Citation Analysis]
137 Tajima-Shirasaki N, Ishii KA, Takayama H, Shirasaki T, Iwama H, Chikamoto K, Saito Y, Iwasaki Y, Teraguchi A, Lan F, Kikuchi A, Takeshita Y, Murao K, Matsugo S, Kaneko S, Misu H, Takamura T. Eicosapentaenoic acid down-regulates expression of the selenoprotein P gene by inhibiting SREBP-1c protein independently of the AMP-activated protein kinase pathway in H4IIEC3 hepatocytes. J Biol Chem 2017;292:10791-800. [PMID: 28465347 DOI: 10.1074/jbc.M116.747006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
138 Lannan KL, Spinelli SL, Blumberg N, Phipps RP. Maresin 1 induces a novel pro-resolving phenotype in human platelets. J Thromb Haemost 2017;15:802-13. [PMID: 28079976 DOI: 10.1111/jth.13620] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
139 Campbell EL, Louis NA, Tomassetti SE, Canny GO, Arita M, Serhan CN, Colgan SP. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 2007;21:3162-3170. [PMID: 17496159 DOI: 10.1096/fj.07-8473com] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 8.9] [Reference Citation Analysis]
140 Marchioli R, Levantesi G, Macchia A, Maggioni A, Marfisi R, Silletta M, Tavazzi L, Tognoni G, Valagussa F. Antiarrhythmic Mechanisms of n-3 PUFA and the Results of the GISSI-Prevenzione Trial. J Membrane Biol 2005;206:117-28. [DOI: 10.1007/s00232-005-0788-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
141 Stopka-farooqui U, Haworth O. Proresolving mediators: new therapies to treat inflammatory diseases. Clinical Lipidology 2015;10:343-50. [DOI: 10.2217/clp.15.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Benavides J, Martínez-valladares M, Tejido M, Giráldez F, Bodas R, Prieto N, Pérez V, Andrés S. Quercetin and flaxseed included in the diet of fattening lambs: Effects on immune response, stress during road transport and ruminal acidosis. Livestock Science 2013;158:84-90. [DOI: 10.1016/j.livsci.2013.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
143 Nagatake T, Kunisawa J. Emerging roles of metabolites of ω3 and ω6 essential fatty acids in the control of intestinal inflammation. Int Immunol 2019;31:569-77. [PMID: 30722032 DOI: 10.1093/intimm/dxy086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
144 Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007;28:176-183. [PMID: 17337246 DOI: 10.1016/j.it.2007.02.007] [Cited by in Crossref: 241] [Cited by in F6Publishing: 224] [Article Influence: 16.1] [Reference Citation Analysis]
145 Rao CV, Janakiram NB, Mohammed A. Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention. Curr Colorectal Cancer Rep 2012;8:316-24. [PMID: 23293573 DOI: 10.1007/s11888-012-0146-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
146 Perucci LO, Sugimoto MA, Gomes KB, Dusse LM, Teixeira MM, Sousa LP. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases. Expert Opin Ther Targets 2017;21:879-96. [PMID: 28786708 DOI: 10.1080/14728222.2017.1364363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
147 Van Dyke TE. The management of inflammation in periodontal disease. J Periodontol 2008;79:1601-8. [PMID: 18673016 DOI: 10.1902/jop.2008.080173] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 10.4] [Reference Citation Analysis]
148 Dasilva G, Medina I. Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators. Free Radic Biol Med 2019;144:90-109. [PMID: 30902758 DOI: 10.1016/j.freeradbiomed.2019.03.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
149 Marion-Letellier R, Butler M, Déchelotte P, Playford RJ, Ghosh S. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation. Am J Clin Nutr 2008;87:939-48. [PMID: 18400717 DOI: 10.1093/ajcn/87.4.939] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 5.1] [Reference Citation Analysis]
150 Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med 2010;8:13. [PMID: 20156336 DOI: 10.1186/1741-7015-8-13] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 8.3] [Reference Citation Analysis]
151 Fujino S, Miyoshi N, Ohue M, Takahashi Y, Yasui M, Sugimura K, Akita H, Takahashi H, Kobayashi S, Yano M, Sakon M. Prediction model and treatment of high-output ileostomy in colorectal cancer surgery. Mol Clin Oncol 2017;7:468-72. [PMID: 28894582 DOI: 10.3892/mco.2017.1336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
152 Murase R, Taketomi Y, Miki Y, Nishito Y, Saito M, Fukami K, Yamamoto K, Murakami M. Group III phospholipase A2 promotes colitis and colorectal cancer. Sci Rep 2017;7:12261. [PMID: 28947740 DOI: 10.1038/s41598-017-12434-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
153 Sommakia S, Baker OJ. Regulation of inflammation by lipid mediators in oral diseases. Oral Dis 2017;23:576-97. [PMID: 27426637 DOI: 10.1111/odi.12544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
154 Ji RR, Xu ZZ, Strichartz G, Serhan CN. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci 2011;34:599-609. [PMID: 21963090 DOI: 10.1016/j.tins.2011.08.005] [Cited by in Crossref: 207] [Cited by in F6Publishing: 198] [Article Influence: 18.8] [Reference Citation Analysis]
155 Quiros M, Feier D, Birkl D, Agarwal R, Zhou DW, García AJ, Parkos CA, Nusrat A. Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing. Proc Natl Acad Sci U S A 2020;117:9477-82. [PMID: 32300016 DOI: 10.1073/pnas.1921335117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
156 Dartt DA, Hodges RR, Li D, Shatos MA, Lashkari K, Serhan CN. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol 2011;186:4455-66. [PMID: 21357260 DOI: 10.4049/jimmunol.1000833] [Cited by in Crossref: 74] [Cited by in F6Publishing: 85] [Article Influence: 6.7] [Reference Citation Analysis]
157 Mayer K, Schaefer MB, Seeger W. Fish oil in the critically ill: from experimental to clinical data. Current Opinion in Clinical Nutrition & Metabolic Care 2006;9:140-8. [DOI: 10.1097/01.mco.0000214573.75062.0a] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
158 Mayer K, Seeger W. Fish oil in critical illness: . Current Opinion in Clinical Nutrition and Metabolic Care 2008;11:121-7. [DOI: 10.1097/mco.0b013e3282f4cdc6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
159 Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 2010;177:1576-91. [PMID: 20813960 DOI: 10.2353/ajpath.2010.100322] [Cited by in Crossref: 289] [Cited by in F6Publishing: 266] [Article Influence: 24.1] [Reference Citation Analysis]
160 Lovegrove C, Ahmed K, Challacombe B, Khan MS, Popert R, Dasgupta P. Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants. Int J Clin Pract 2015;69:87-105. [PMID: 25495842 DOI: 10.1111/ijcp.12514] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
161 Wu D, Lewis ED, Pae M, Meydani SN. Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance. Front Immunol 2018;9:3160. [PMID: 30697214 DOI: 10.3389/fimmu.2018.03160] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 38.7] [Reference Citation Analysis]
162 Saito Y. Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess. J Clin Biochem Nutr 2020;66:1-7. [PMID: 32001950 DOI: 10.3164/jcbn.19-31] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
163 Kataoka Y, Uno K, Puri R, Nicholls SJ. Epanova ® and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy. Future Cardiology 2013;9:177-86. [DOI: 10.2217/fca.13.4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
164 Yum H, Kang JX, Hahm KB, Surh Y. Constitutive ω-3 fatty acid production in fat - 1 transgenic mice and docosahexaenoic acid administration to wild type mice protect against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Biochemical and Biophysical Research Communications 2017;487:847-55. [DOI: 10.1016/j.bbrc.2017.04.140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
165 Sima C, Paster B, Van Dyke TE. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes. Crit Rev Immunol 2018;38:343-65. [PMID: 30806214 DOI: 10.1615/CritRevImmunol.2018026750] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
166 Wittwer J, Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins, Leukotrienes and Essential Fatty Acids 2007;77:67-77. [DOI: 10.1016/j.plefa.2007.08.001] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 8.1] [Reference Citation Analysis]
167 Honda T, Kabashima K. Current understanding of the role of dietary lipids in the pathophysiology of psoriasis. J Dermatol Sci 2019;94:314-20. [PMID: 31133503 DOI: 10.1016/j.jdermsci.2019.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621. [PMID: 20192811 DOI: 10.1146/annurev-immunol-030409-101225.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 Arukwe A, Cangialosi MV, Letcher RJ, Rocha E, Mortensen AS. Changes in morphometry and association between whole-body fatty acids and steroid hormone profiles in relation to bioaccumulation patterns in salmon larvae exposed to perfluorooctane sulfonic or perfluorooctane carboxylic acids. Aquatic Toxicology 2013;130-131:219-30. [DOI: 10.1016/j.aquatox.2012.12.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
170 Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Res Rev 2007;56:443-71. [PMID: 17959252 DOI: 10.1016/j.brainresrev.2007.09.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
171 Calder PC. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie. 2009;91:791-795. [PMID: 19455748 DOI: 10.1016/j.biochi.2009.01.008] [Cited by in Crossref: 448] [Cited by in F6Publishing: 391] [Article Influence: 34.5] [Reference Citation Analysis]
172 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
173 Yatomi M, Hisada T, Ishizuka T, Koga Y, Ono A, Kamide Y, Seki K, Aoki-Saito H, Tsurumaki H, Sunaga N, Kaira K, Dobashi K, Yamada M, Okajima F. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep 2015;3:e12628. [PMID: 26660549 DOI: 10.14814/phy2.12628] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
174 Chen YC, Chen YY, Yeh HW, Yeh TY, Huang JY, Liao PL, Yeh LT, Yang SF, Chou MC, Yeh CB. Association Between Aspirin Use and Decreased Risk of Pneumonia in Patients With Cardio-Cerebra-Vascular Ischemic Disease: A Population-Based Cohort Study. Front Public Health 2021;9:625834. [PMID: 33816418 DOI: 10.3389/fpubh.2021.625834] [Reference Citation Analysis]
175 Lu J, Jilling T, Li D, Caplan MS. Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 2007;61:427-32. [PMID: 17515866 DOI: 10.1203/pdr.0b013e3180332ca5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
176 Levy BD, Zhang QY, Bonnans C, Primo V, Reilly JJ, Perkins DL, Liang Y, Amin Arnaout M, Nikolic B, Serhan CN. The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins Leukot Essent Fatty Acids 2011;84:43-50. [PMID: 20869861 DOI: 10.1016/j.plefa.2010.09.002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
177 González-Périz A, Planagumà A, Gronert K, Miquel R, López-Parra M, Titos E, Horrillo R, Ferré N, Deulofeu R, Arroyo V, Rodés J, Clària J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 2006;20:2537-9. [PMID: 17056761 DOI: 10.1096/fj.06-6250fje] [Cited by in Crossref: 151] [Cited by in F6Publishing: 150] [Article Influence: 9.4] [Reference Citation Analysis]
178 Kotlyarov S, Kotlyarova A. Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:12803. [PMID: 34884621 DOI: 10.3390/ijms222312803] [Reference Citation Analysis]
179 Diaz Encarnacion MM, Warner GM, Cheng J, Gray CE, Nath KA, Grande JP. n-3 Fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells. Am J Physiol Renal Physiol 2011;300:F1142-51. [PMID: 21367920 DOI: 10.1152/ajprenal.00064.2011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
180 Naqvi RA, Gupta M, George A, Naqvi AR. MicroRNAs in shaping the resolution phase of inflammation. Semin Cell Dev Biol 2021:S1084-9521(21)00066-5. [PMID: 33934990 DOI: 10.1016/j.semcdb.2021.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
181 Vassiliou EK, Gonzalez A, Garcia C, Tadros JH, Chakraborty G, Toney JH. Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems. Lipids Health Dis 2009;8:25. [PMID: 19558671 DOI: 10.1186/1476-511X-8-25] [Cited by in Crossref: 144] [Cited by in F6Publishing: 51] [Article Influence: 11.1] [Reference Citation Analysis]
182 Recchiuti A, Serhan CN. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. Front Immunol. 2012;3:298. [PMID: 23093949 DOI: 10.3389/fimmu.2012.00298] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
183 Murase R, Sato H, Yamamoto K, Ushida A, Nishito Y, Ikeda K, Kobayashi T, Yamamoto T, Taketomi Y, Murakami M. Group X Secreted Phospholipase A2 Releases ω3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm Fertility. J Biol Chem 2016;291:6895-911. [PMID: 26828067 DOI: 10.1074/jbc.M116.715672] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
184 Baranowski M, Enns J, Blewett H, Yakandawala U, Zahradka P, Taylor CG. Dietary flaxseed oil reduces adipocyte size, adipose monocyte chemoattractant protein-1 levels and T-cell infiltration in obese, insulin-resistant rats. Cytokine 2012;59:382-91. [DOI: 10.1016/j.cyto.2012.04.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
185 Kang JX, Liu A. The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis. Cancer Metastasis Rev. 2013;32:201-210. [PMID: 23090260 DOI: 10.1007/s10555-012-9401-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
186 Freire MO, Dalli J, Serhan CN, Van Dyke TE. Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes. J Immunol 2017;198:718-28. [PMID: 27994073 DOI: 10.4049/jimmunol.1601543] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
187 Renuka, Kumar S, Sharma B, Sharma P, Agnihotri N. n-3 PUFAs: an Elixir in Prevention of Colorectal Cancer. Curr Colorectal Cancer Rep 2015;11:141-9. [DOI: 10.1007/s11888-015-0268-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
188 Ishizuka T, Hisada T, Aoki H, Mori M. Resolvin E1: a novel lipid mediator in the resolution of allergic airway inflammation. Expert Rev Clin Immunol 2008;4:669-72. [PMID: 20477116 DOI: 10.1586/1744666X.4.6.669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
189 Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun Y, Uddin J, Petasis NA, Serhan CN. Metabolic Inactivation of Resolvin E1 and Stabilization of Its Anti-inflammatory Actions. Journal of Biological Chemistry 2006;281:22847-54. [DOI: 10.1074/jbc.m603766200] [Cited by in Crossref: 103] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
190 Huang CH, Hou YC, Pai MH, Yeh CL, Yeh SL. Dietary ω-6/ω-3 Polyunsaturated Fatty Acid Ratios Affect the Homeostasis of Th/Treg Cells in Mice With Dextran Sulfate Sodium-Induced Colitis. JPEN J Parenter Enteral Nutr 2017;41:647-56. [PMID: 27006408 DOI: 10.1177/0148607116638493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
191 Kaur G, Begg DP, Barr D, Garg M, Cameron-smith D, Sinclair AJ. Short-term docosapentaenoic acid (22 : 5 n -3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats. Br J Nutr 2010;103:32-7. [DOI: 10.1017/s0007114509991334] [Cited by in Crossref: 67] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
192 Irún P, Lanas A, Piazuelo E. Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review. Front Pharmacol 2019;10:852. [PMID: 31427966 DOI: 10.3389/fphar.2019.00852] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
193 Zhang J, Wang M, Ding W, Zhao M, Ye J, Xu Y, Wang Z, Ye D, Li D, Liu J, Wan J. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling. Biochem Pharmacol 2020;180:114188. [PMID: 32750329 DOI: 10.1016/j.bcp.2020.114188] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
194 Prescott D, Atkinson B, Döring A, Brown S, Petri B, McKay DM, Waterhouse CC. Loss of phosphoinositide 3-kinase P110γ is protective in the acute phase but detrimental in the resolution phase of hapten-induced colitis. Inflamm Bowel Dis 2013;19:489-500. [PMID: 23282580 DOI: 10.1097/MIB.0b013e31827feb84] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
195 Enke U, Seyfarth L, Schleussner E, Markert UR. Impact of PUFA on early immune and fetal development. Br J Nutr 2008;100:1158-68. [PMID: 18590581 DOI: 10.1017/S000711450801413X] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
196 Chan SS, Luben R, Olsen A, Tjonneland A, Kaaks R, Lindgren S, Grip O, Bergmann MM, Boeing H, Hallmans G. Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn’s disease. Aliment Pharmacol Ther. 2014;39:834-842. [PMID: 24611981 DOI: 10.1111/apt.12670] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
197 Filep JG, Ariel A. Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of inflammation. Am J Physiol Cell Physiol 2020;319:C510-32. [PMID: 32667864 DOI: 10.1152/ajpcell.00181.2020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
198 Ramon S, Gao F, Serhan CN, Phipps RP. Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J Immunol 2012;189:1036-42. [PMID: 22711890 DOI: 10.4049/jimmunol.1103483] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 8.3] [Reference Citation Analysis]
199 Anderson P, Delgado M. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders. J Cell Mol Med 2008;12:1830-47. [PMID: 18554314 DOI: 10.1111/j.1582-4934.2008.00387.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
200 Gilroy DW, Bishop-Bailey D. Lipid mediators in immune regulation and resolution. Br J Pharmacol 2019;176:1009-23. [PMID: 30674066 DOI: 10.1111/bph.14587] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
201 Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, Calixto JB. Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J Immunol. 2013;191:4288-4298. [PMID: 24038091 DOI: 10.4049/jimmunol.1202743] [Cited by in Crossref: 121] [Cited by in F6Publishing: 123] [Article Influence: 13.4] [Reference Citation Analysis]
202 Saunders EF, Reider A, Singh G, Gelenberg AJ, Rapoport SI. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment. Bipolar Disord 2015;17:729-42. [PMID: 26424416 DOI: 10.1111/bdi.12337] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
203 Morimoto M, Lee EY, Zhang X, Inaba Y, Inoue H, Ogawa M, Shirasawa T, Yokosuka O, Miki T. Eicosapentaenoic acid ameliorates hyperglycemia in high-fat diet-sensitive diabetes mice in conjunction with restoration of hypoadiponectinemia. Nutr Diabetes 2016;6:e213. [PMID: 27348201 DOI: 10.1038/nutd.2016.21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
204 Boussetta T, Raad H, Lettéron P, Gougerot-Pocidalo MA, Marie JC, Driss F, El-Benna J. Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One. 2009;4:e6458. [PMID: 19649246 DOI: 10.1371/journal.pone.0006458] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
205 Mayer K, Sommer N, Hache K, Hecker A, Reiche S, Schneck E, Weissmann N, Seeger W, Hecker M. Resolvin E1 Improves Mitochondrial Function in Human Alveolar Epithelial Cells during Severe Inflammation. Lipids 2019;54:53-65. [DOI: 10.1002/lipd.12119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
206 Qu Q, Xuan W, Fan GH. Roles of resolvins in the resolution of acute inflammation. Cell Biol Int 2015;39:3-22. [PMID: 25052386 DOI: 10.1002/cbin.10345] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
207 Haas-Stapleton EJ, Lu Y, Hong S, Arita M, Favoreto S, Nigam S, Serhan CN, Agabian N. Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. PLoS One 2007;2:e1316. [PMID: 18091990 DOI: 10.1371/journal.pone.0001316] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
208 Wallace JL. Commonality of defensive roles of COX-2 in the lung and gut. Am J Pathol 2006;168:1060-3. [PMID: 16565482 DOI: 10.2353/ajpath.2006.060023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
209 Yamashita A, Kawana K, Tomio K, Taguchi A, Isobe Y, Iwamoto R, Masuda K, Furuya H, Nagamatsu T, Nagasaka K, Arimoto T, Oda K, Wada-Hiraike O, Yamashita T, Taketani Y, Kang JX, Kozuma S, Arai H, Arita M, Osuga Y, Fujii T. Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birth. Sci Rep 2013;3:3113. [PMID: 24177907 DOI: 10.1038/srep03113] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
210 Krishnamoorthy S, Recchiuti A, Chiang N, Fredman G, Serhan CN. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am J Pathol 2012;180:2018-27. [PMID: 22449948 DOI: 10.1016/j.ajpath.2012.01.028] [Cited by in Crossref: 164] [Cited by in F6Publishing: 168] [Article Influence: 16.4] [Reference Citation Analysis]
211 Duffney PF, Falsetta ML, Rackow AR, Thatcher TH, Phipps RP, Sime PJ. Key roles for lipid mediators in the adaptive immune response. J Clin Invest 2018;128:2724-31. [PMID: 30108196 DOI: 10.1172/JCI97951] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
212 Bükki J, Stanga Z, Tellez FB, Duclos K, Kolev M, Krähenmann P, Pabst T, Iff S, Jüni P. Omega-3 Poly-Unsaturated Fatty Acids for the Prevention of Severe Neutropenic Enterocolitis in Patients with Acute Myeloid Leukemia. Nutrition and Cancer 2013;65:834-42. [DOI: 10.1080/01635581.2013.801998] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
213 Umrania VV, Rao Deepika PC, Kulkarni M. Evaluation of dietary supplementation of omega-3 polyunsaturated fatty acids as an adjunct to scaling and root planing on salivary interleukin-1β levels in patients with chronic periodontitis: A clinico-immunological study. J Indian Soc Periodontol 2017;21:386-90. [PMID: 29491585 DOI: 10.4103/jisp.jisp_16_16] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
214 Sugihara K, Morhardt TL, Kamada N. The Role of Dietary Nutrients in Inflammatory Bowel Disease. Front Immunol 2018;9:3183. [PMID: 30697218 DOI: 10.3389/fimmu.2018.03183] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
215 Kang GJ, Lee HJ, Byun HJ, Kim EJ, Kim HJ, Park MK, Lee CH. Novel involvement of miR-522-3p in high-mobility group box 1-induced prostaglandin reductase 1 expression and reduction of phagocytosis. Biochim Biophys Acta Mol Cell Res 2017;1864:625-33. [PMID: 28088550 DOI: 10.1016/j.bbamcr.2017.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
216 Parolini C. Effects of Fish n-3 PUFAs on Intestinal Microbiota and Immune System. Mar Drugs 2019;17:E374. [PMID: 31234533 DOI: 10.3390/md17060374] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
217 Yazdi PG. A review of the biologic and pharmacologic role of docosapentaenoic acid n-3. F1000Res 2013;2:256. [PMID: 25232466 DOI: 10.12688/f1000research.2-256.v2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
218 Poulsen RC, Gotlinger KH, Serhan CN, Kruger MC. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am J Hematol 2008;83:437-45. [PMID: 18429055 DOI: 10.1002/ajh.21170] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
219 Weylandt KH, Kang JX. Rethinking lipid mediators. The Lancet 2005;366:618-20. [DOI: 10.1016/s0140-6736(05)67119-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
220 Kaur G, Cameron-smith D, Garg M, Sinclair AJ. Docosapentaenoic acid (22:5n-3): A review of its biological effects. Progress in Lipid Research 2011;50:28-34. [DOI: 10.1016/j.plipres.2010.07.004] [Cited by in Crossref: 220] [Cited by in F6Publishing: 189] [Article Influence: 20.0] [Reference Citation Analysis]
221 Gong Y, Lin M, Piao L, Li X, Yang F, Zhang J, Xiao B, Zhang Q, Song WL, Yin H, Zhu L, Funk CD, Yu Y. Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling. Br J Pharmacol 2015;172:5647-60. [PMID: 25339093 DOI: 10.1111/bph.12986] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
222 Karthikkumar V, Sivagami G, Viswanathan P, Nalini N. Rosmarinic acid inhibits DMH-induced cell proliferation in experimental rats. Journal of Basic and Clinical Physiology and Pharmacology 2015;26. [DOI: 10.1515/jbcpp-2014-0044] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
223 Lin N, Shay JES, Xie H, Lee DSM, Skuli N, Tang Q, Zhou Z, Azzam A, Meng H, Wang H, FitzGerald GA, Simon MC. Myeloid Cell Hypoxia-Inducible Factors Promote Resolution of Inflammation in Experimental Colitis. Front Immunol 2018;9:2565. [PMID: 30455703 DOI: 10.3389/fimmu.2018.02565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
224 Dangi B, Obeng M, Nauroth JM, Chung G, Bailey-Hall E, Hallenbeck T, Arterburn LM. Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6). Biochem Pharmacol 2010;79:251-60. [PMID: 19679107 DOI: 10.1016/j.bcp.2009.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
225 Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007;129:210-23. [DOI: 10.1016/j.pain.2007.01.020] [Cited by in Crossref: 307] [Cited by in F6Publishing: 237] [Article Influence: 20.5] [Reference Citation Analysis]
226 Ritchie SA, Heath D, Yamazaki Y, Grimmalt B, Kavianpour A, Krenitsky K, Elshoni H, Takemasa I, Miyake M, Sekimoto M, Monden M, Tomonaga T, Matsubara H, Sogawa K, Matsushita K, Nomura F, Goodenowe DB. Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age. BMC Gastroenterol 2010;10:140. [PMID: 21114854 DOI: 10.1186/1471-230X-10-140] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
227 Moranis A, Delpech JC, De Smedt-Peyrusse V, Aubert A, Guesnet P, Lavialle M, Joffre C, Layé S. Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice. Brain Behav Immun 2012;26:721-31. [PMID: 22085587 DOI: 10.1016/j.bbi.2011.11.001] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
228 Beharry S, Ackerley C, Corey M, Kent G, Heng Y, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007;292:G839-48. [DOI: 10.1152/ajpgi.00582.2005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
229 Liu G, Gong Y, Zhang R, Piao L, Li X, Liu Q, Yan S, Shen Y, Guo S, Zhu M, Yin H, Funk CD, Zhang J, Yu Y. Resolvin E1 attenuates inj ury‐induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration. FASEB j 2018;32:5413-25. [DOI: 10.1096/fj.201800173r] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
230 Zhu Q, Xue Z, Yadav N, Damude H, Pollak DW, Rupert R, Seip J, Hollerbach D, Macool D, Zhang H, Bledsoe S, Short D, Tyreus B, Kinney A, Picataggio S. Metabolic Engineering of an Oleaginous Yeast for the Production of Omega-3 Fatty Acids. Single Cell Oils. Elsevier; 2010. pp. 51-73. [DOI: 10.1016/b978-1-893997-73-8.50007-4] [Cited by in Crossref: 11] [Article Influence: 0.9] [Reference Citation Analysis]
231 Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE, Serhan CN. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem 2010;285:3451-61. [PMID: 19906641 DOI: 10.1074/jbc.M109.044131] [Cited by in Crossref: 170] [Cited by in F6Publishing: 109] [Article Influence: 13.1] [Reference Citation Analysis]
232 Mizota T, Fujita-Kambara C, Matsuya N, Hamasaki S, Fukudome T, Goto H, Nakane S, Kondo T, Matsuo H. Effect of dietary fatty acid composition on Th1/Th2 polarization in lymphocytes. JPEN J Parenter Enteral Nutr 2009;33:390-6. [PMID: 19221048 DOI: 10.1177/0148607108325252] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
233 Maskrey BH, Megson IL, Rossi AG, Whitfield PD. Emerging importance of omega-3 fatty acids in the innate immune response: molecular mechanisms and lipidomic strategies for their analysis. Mol Nutr Food Res 2013;57:1390-400. [PMID: 23417926 DOI: 10.1002/mnfr.201200723] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
234 Komprda T, Sladek Z, Sevcikova Z, Svehlova V, Wijacki J, Guran R, Do T, Lackova Z, Polanska H, Vrlikova L, Popelkova V, Michalek P, Zitka O, Buchtova M. Comparison of Dietary Oils with Different Polyunsaturated Fatty Acid n-3 and n-6 Content in the Rat Model of Cutaneous Wound Healing. Int J Mol Sci 2020;21:E7911. [PMID: 33114430 DOI: 10.3390/ijms21217911] [Reference Citation Analysis]
235 Calder PC. n -3 PUFA and inflammation: from membrane to nucleus and from bench to bedside. Proc Nutr Soc 2020;79:404-16. [DOI: 10.1017/s0029665120007077] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
236 Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013;19:650-661. [PMID: 23328774 DOI: 10.1097/mib.0b013e3182810122] [Cited by in Crossref: 61] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
237 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
238 Libreros S, Shay AE, Nshimiyimana R, Fichtner D, Martin MJ, Wourms N, Serhan CN. A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution. Front Immunol 2020;11:631319. [PMID: 33643307 DOI: 10.3389/fimmu.2020.631319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
239 Matthews JD, Weight CM, Parkos CA. Leukocyte-epithelial interactions and mucosal homeostasis. Toxicol Pathol. 2014;42:91-98. [PMID: 24285670 DOI: 10.1177/0192623313511336] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
240 Serhan CN. Resolvins and protectins: novel lipid mediators in anti-inflammation and resolution. Scandinavian Journal of Food and Nutrition 2016;50:68-78. [DOI: 10.1080/17482970601066298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
241 Kang JX, Weylandt KH. Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem. 2008;49:133-143. [PMID: 18751910 DOI: 10.1007/978-1-4020-8831-5_5] [Cited by in Crossref: 103] [Cited by in F6Publishing: 88] [Article Influence: 7.4] [Reference Citation Analysis]
242 Keyes KT, Ye Y, Lin Y, Zhang C, Perez-Polo JR, Gjorstrup P, Birnbaum Y. Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2010;299:H153-64. [PMID: 20435846 DOI: 10.1152/ajpheart.01057.2009] [Cited by in Crossref: 109] [Cited by in F6Publishing: 113] [Article Influence: 9.1] [Reference Citation Analysis]
243 Jones-Hall YL, Grisham MB. Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease. Pathophysiology. 2014;21:267-288. [PMID: 24935242 DOI: 10.1016/j.pathophys.2014.05.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
244 Yacoubian S, Serhan CN. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007;3:570-579; quiz 1 p following 589. [PMID: 17906612 DOI: 10.1038/ncprheum0616] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
245 Tanaka T, Shen J, Abecasis GR, Kisialiou A, Ordovas JM, Guralnik JM, Singleton A, Bandinelli S, Cherubini A, Arnett D, Tsai MY, Ferrucci L. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet 2009;5:e1000338. [PMID: 19148276 DOI: 10.1371/journal.pgen.1000338] [Cited by in Crossref: 272] [Cited by in F6Publishing: 273] [Article Influence: 20.9] [Reference Citation Analysis]
246 Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13:868-873. [PMID: 17589522 DOI: 10.1038/nm1591] [Cited by in Crossref: 438] [Cited by in F6Publishing: 409] [Article Influence: 29.2] [Reference Citation Analysis]
247 Hong S, Porter TF, Lu Y, Oh SF, Pillai PS, Serhan CN. Resolvin E1 metabolome in local inactivation during inflammation-resolution. J Immunol 2008;180:3512-9. [PMID: 18292578 DOI: 10.4049/jimmunol.180.5.3512] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
248 Abdolmaleki F, Kovanen PT, Mardani R, Gheibi-Hayat SM, Bo S, Sahebkar A. Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases. Clin Rev Allergy Immunol 2020;58:82-91. [PMID: 31267470 DOI: 10.1007/s12016-019-08754-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
249 Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2015;7:a016311. [PMID: 25359497 DOI: 10.1101/cshperspect.a016311] [Cited by in Crossref: 218] [Cited by in F6Publishing: 208] [Article Influence: 27.3] [Reference Citation Analysis]
250 Jeon YD, Bang KS, Shin MK, Lee JH, Chang YN, Jin JS. Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis. BMC Complement Altern Med 2016;16:459. [PMID: 27846836 DOI: 10.1186/s12906-016-1390-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
251 Ito S, Sano Y, Nagasawa K, Matsuura N, Yamada Y, Uchinaka A, Murohara T, Nagata K. Highly purified eicosapentaenoic acid ameliorates cardiac injury and adipose tissue inflammation in a rat model of metabolic syndrome. Obes Sci Pract 2016;2:318-29. [PMID: 27708849 DOI: 10.1002/osp4.50] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
252 Janakiram NB, Rao CV. The role of inflammation in colon cancer. Adv Exp Med Biol. 2014;816:25-52. [PMID: 24818718 DOI: 10.1007/978-3-0348-0837-8_2] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 12.0] [Reference Citation Analysis]
253 Duvall MG, Levy BD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol 2016;785:144-55. [PMID: 26546247 DOI: 10.1016/j.ejphar.2015.11.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
254 Schwanke RC, Marcon R, Bento AF, Calixto JB. EPA- and DHA-derived resolvins' actions in inflammatory bowel disease. Eur J Pharmacol 2016;785:156-64. [PMID: 26325092 DOI: 10.1016/j.ejphar.2015.08.050] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
255 Luissint AC, Parkos CA, Nusrat A. Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair. Gastroenterology 2016;151:616-32. [PMID: 27436072 DOI: 10.1053/j.gastro.2016.07.008] [Cited by in Crossref: 177] [Cited by in F6Publishing: 166] [Article Influence: 29.5] [Reference Citation Analysis]
256 Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, Serhan CN, Kang JX. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA. 2006;103:11276-11281. [PMID: 16847262 DOI: 10.1073/pnas.0601280103] [Cited by in Crossref: 285] [Cited by in F6Publishing: 268] [Article Influence: 17.8] [Reference Citation Analysis]
257 Seki H, Tani Y, Arita M. Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. Prostaglandins Other Lipid Mediat. 2009;89:126-130. [PMID: 19737659 DOI: 10.1016/j.prostaglandins.2009.03.002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
258 Janakiram NB, Mohammed A, Rao CV. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Rev. 2011;30:507-523. [PMID: 22015691 DOI: 10.1007/s10555-011-9311-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 5.7] [Reference Citation Analysis]
259 Chapkin RS, McMurray DN, Lupton JR. Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol. 2007;23:48-54. [PMID: 17133085 DOI: 10.1097/mog.0b013e32801145d7] [Cited by in Crossref: 97] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
260 Yoo S, Lim JY, Hwang SW. Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives. Curr Neuropharmacol 2013;11:664-76. [PMID: 24396341 DOI: 10.2174/1570159X11311060009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
261 Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther 2018;186:98-113. [PMID: 29352860 DOI: 10.1016/j.pharmthera.2018.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
262 Sawada Y, Honda T, Hanakawa S, Nakamizo S, Murata T, Ueharaguchi-Tanada Y, Ono S, Amano W, Nakajima S, Egawa G, Tanizaki H, Otsuka A, Kitoh A, Dainichi T, Ogawa N, Kobayashi Y, Yokomizo T, Arita M, Nakamura M, Miyachi Y, Kabashima K. Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses. J Exp Med 2015;212:1921-30. [PMID: 26438363 DOI: 10.1084/jem.20150381] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 9.4] [Reference Citation Analysis]
263 Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood. 2008;112:848-855. [PMID: 18480426 DOI: 10.1182/blood-2007-11-122598] [Cited by in Crossref: 153] [Cited by in F6Publishing: 146] [Article Influence: 10.9] [Reference Citation Analysis]
264 Menter DG, Davis JS, Tucker SC, Hawk E, Crissman JD, Sood AK, Kopetz S, Honn KV. Platelets: “First Responders” in Cancer Progression and Metastasis. In: Gresele P, Kleiman NS, Lopez JA, Page CP, editors. Platelets in Thrombotic and Non-Thrombotic Disorders. Cham: Springer International Publishing; 2017. pp. 1111-32. [DOI: 10.1007/978-3-319-47462-5_74] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
265 Marion-Letellier R, Savoye G, Ghosh S. Fatty acids, eicosanoids and PPAR gamma. Eur J Pharmacol. 2016;785:44-49. [PMID: 26632493 DOI: 10.1016/j.ejphar.2015.11.004] [Cited by in Crossref: 105] [Cited by in F6Publishing: 87] [Article Influence: 15.0] [Reference Citation Analysis]
266 Wang F, Fu Y, Cai W, Sinclair AJ, Li D. Anti-inflammatory activity and mechanisms of a lipid extract from hard-shelled mussel ( Mytilus coruscus ) in mice with dextran sulphate sodium-induced colitis. Journal of Functional Foods 2016;23:389-99. [DOI: 10.1016/j.jff.2016.03.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
267 Duarte LRF, Pinho V, Rezende BM, Teixeira MM. Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives. Biomolecules 2022;12:75. [DOI: 10.3390/biom12010075] [Reference Citation Analysis]
268 Kim TH, Kim GD, Jin YH, Park YS, Park CS. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice. Int Immunopharmacol 2012;14:384-91. [PMID: 22951188 DOI: 10.1016/j.intimp.2012.08.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
269 Erdinest N, Ovadia H, Kormas R, Solomon A. Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study. J Inflamm (Lond) 2014;11:6. [PMID: 24580770 DOI: 10.1186/1476-9255-11-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
270 Jo YY, Lee JY, Park CK. Resolvin E1 Inhibits Substance P-Induced Potentiation of TRPV1 in Primary Sensory Neurons. Mediators Inflamm 2016;2016:5259321. [PMID: 27738388 DOI: 10.1155/2016/5259321] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
271 Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins, Leukotrienes and Essential Fatty Acids 2008;79:101-8. [DOI: 10.1016/j.plefa.2008.09.016] [Cited by in Crossref: 295] [Cited by in F6Publishing: 275] [Article Influence: 21.1] [Reference Citation Analysis]
272 Jeon YD, Kang SH, Bang KS, Chang YN, Lee JH, Jin JS. Glycyrrhetic Acid Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Vivo. Molecules 2016;21:523. [PMID: 27110761 DOI: 10.3390/molecules21040523] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
273 Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, Takeda J, Levy BD. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol 2010;184:836-43. [PMID: 20007539 DOI: 10.4049/jimmunol.0901809] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 10.8] [Reference Citation Analysis]
274 Zhao XW, Bao JJ, Hu C, Ding H, Liu XC, Mei Q, Xu JM. Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis. Dig Dis Sci 2014;59:2992-6. [PMID: 25030943 DOI: 10.1007/s10620-014-3280-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
275 Yoshimura T, Oppenheim JJ. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res 2011;317:674-84. [PMID: 21056554 DOI: 10.1016/j.yexcr.2010.10.023] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 8.1] [Reference Citation Analysis]
276 Hasturk H, Kantarci A, Goguet-Surmenian E, Blackwood A, Andry C, Serhan CN, Van Dyke TE. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. 2007;179:7021-7029. [PMID: 17982093 DOI: 10.4049/jimmunol.179.10.7021] [Cited by in Crossref: 282] [Cited by in F6Publishing: 264] [Article Influence: 18.8] [Reference Citation Analysis]
277 Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007;30:980-92. [PMID: 17978156 DOI: 10.1183/09031936.00005807] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
278 Gao M, Jiang Y, Xiao X, Peng Y, Xiao X, Yang M. Protective effect of pioglitazone on sepsis-induced intestinal injury in a rodent model. J Surg Res 2015;195:550-8. [PMID: 25772146 DOI: 10.1016/j.jss.2015.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
279 Medeiros FJ, Aguila MB, Mandarim-de-Lacerda CA. Renal cortex remodeling in streptozotocin-induced diabetic spontaneously hypertensive rats treated with olive oil, palm oil and fish oil from Menhaden. Prostaglandins Leukot Essent Fatty Acids 2006;75:357-65. [PMID: 16919431 DOI: 10.1016/j.plefa.2006.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
280 Flesher RP, Herbert C, Kumar RK. Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma. Clin Sci (Lond) 2014;126:805-14. [PMID: 24344649 DOI: 10.1042/CS20130623] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
281 Kim B, Guaregua V, Chen X, Zhao C, Yeow W, Berg NK, Eltzschig HK, Yuan X. Characterization of a Murine Model System to Study MicroRNA-147 During Inflammatory Organ Injury. Inflammation 2021;44:1426-40. [PMID: 33566257 DOI: 10.1007/s10753-021-01427-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Matsuda Y, Habu D, Lee S, Kishida S, Osugi H. Enteral Diet Enriched with ω-3 Fatty Acid Improves Oxygenation After Thoracic Esophagectomy for Cancer: A Randomized Controlled Trial. World J Surg 2017;41:1584-94. [DOI: 10.1007/s00268-017-3893-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
283 Martin JM, Stapleton RD. Omega-3 fatty acids in critical illness. Nutr Rev. 2010;68:531-541. [PMID: 20796218 DOI: 10.1111/j.1753-4887.2010.00313.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
284 Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther 2021;218:107670. [PMID: 32891711 DOI: 10.1016/j.pharmthera.2020.107670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
285 Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007;178:3912-7. [PMID: 17339491 DOI: 10.4049/jimmunol.178.6.3912] [Cited by in Crossref: 402] [Cited by in F6Publishing: 368] [Article Influence: 26.8] [Reference Citation Analysis]
286 Van Dyke TE. Proresolving lipid mediators: potential for prevention and treatment of periodontitis. J Clin Periodontol 2011;38 Suppl 11:119-25. [PMID: 21323709 DOI: 10.1111/j.1600-051X.2010.01662.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
287 D'Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC. Targeting the "cytokine storm" for therapeutic benefit. Clin Vaccine Immunol. 2013;20:319-327. [PMID: 23283640 DOI: 10.1128/cvi.00636-12] [Cited by in Crossref: 164] [Cited by in F6Publishing: 97] [Article Influence: 18.2] [Reference Citation Analysis]
288 El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, Hasturk H, Van Dyke TE. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol. 2010;81:1635-1643. [PMID: 20572767 DOI: 10.1902/jop.2010.090628] [Cited by in Crossref: 102] [Cited by in F6Publishing: 91] [Article Influence: 8.5] [Reference Citation Analysis]
289 Lee HN, Na HK, Surh YJ. Resolution of inflammation as a novel chemopreventive strategy. Semin Immunopathol 2013;35:151-61. [PMID: 23370700 DOI: 10.1007/s00281-013-0363-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
290 Cash JL, Bass MD, Campbell J, Barnes M, Kubes P, Martin P. Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring. Curr Biol 2014;24:1406-14. [PMID: 24881877 DOI: 10.1016/j.cub.2014.05.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
291 Panigrahy D, Gilligan MM, Serhan CN, Kashfi K. Resolution of inflammation: An organizing principle in biology and medicine. Pharmacol Ther 2021;:107879. [PMID: 33915177 DOI: 10.1016/j.pharmthera.2021.107879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
292 Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol 2011;186:1735-46. [PMID: 21187448 DOI: 10.4049/jimmunol.1003456] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 7.3] [Reference Citation Analysis]
293 Westbrook AM, Szakmary A, Schiestl RH. RETRACTED ARTICLE: Mouse models of intestinal inflammation and cancer. Arch Toxicol 2016;90:2109-30. [DOI: 10.1007/s00204-016-1747-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
294 Kim W, McMurray DN, Chapkin RS. Chemotherapeutic Properties of n-3 Polyunsaturated Fatty Acids - Old Concepts and New Insights. Immunol Endocr Metab Agents Med Chem 2009;9:38-44. [PMID: 19823600 DOI: 10.2174/187152209788009841] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
295 de Castro GS, Calder PC. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition 2018;37:37-55. [DOI: 10.1016/j.clnu.2017.01.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 13.8] [Reference Citation Analysis]
296 Isobe Y, Arita M. Identification of novel omega-3 fatty acid-derived bioactive metabolites based on a targeted lipidomics approach. J Clin Biochem Nutr 2014;55:79-84. [PMID: 25320453 DOI: 10.3164/jcbn.14-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
297 Shaikh SR, Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr 2006;84:1277-89. [PMID: 17158407 DOI: 10.1093/ajcn/84.6.1277] [Cited by in Crossref: 123] [Cited by in F6Publishing: 105] [Article Influence: 8.2] [Reference Citation Analysis]
298 de Paiva CS, Schwartz CE, Gjörstrup P, Pflugfelder SC. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea 2012;31:1299-303. [PMID: 22257864 DOI: 10.1097/ICO.0b013e31823f789e] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
299 Biasi F, Leonarduzzi G, Oteiza PI, Poli G. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19:1711-1747. [PMID: 23305298 DOI: 10.1089/ars.2012.4530] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 13.1] [Reference Citation Analysis]
300 Trilleaud C, Gauttier V, Biteau K, Girault I, Belarif L, Mary C, Pengam S, Teppaz G, Thepenier V, Danger R, Robert-Siegwald G, Néel M, Bruneau S, Glémain A, Néel A, Poupon A, Mosnier JF, Chêne G, Dubourdeau M, Blancho G, Vanhove B, Poirier N. Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution. Sci Adv 2021;7:eabd1453. [PMID: 33811066 DOI: 10.1126/sciadv.abd1453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
301 Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75:645-662. [PMID: 22765297 DOI: 10.1111/j.1365-2125.2012.04374.x] [Cited by in Crossref: 646] [Cited by in F6Publishing: 569] [Article Influence: 71.8] [Reference Citation Analysis]
302 Uddin M, Levy BD. Resolvins: natural agonists for resolution of pulmonary inflammation. Prog Lipid Res 2011;50:75-88. [PMID: 20887750 DOI: 10.1016/j.plipres.2010.09.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
303 Stables MJ, Gilroy DW. Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res. 2011;50:35-51. [PMID: 20655950 DOI: 10.1016/j.plipres.2010.07.005] [Cited by in Crossref: 211] [Cited by in F6Publishing: 199] [Article Influence: 17.6] [Reference Citation Analysis]
304 Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem 2015;71:341-9. [PMID: 25752887 DOI: 10.1007/s13105-015-0395-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
305 Uranga JA, López-Miranda V, Lombó F, Abalo R. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol Rep 2016;68:816-26. [PMID: 27267792 DOI: 10.1016/j.pharep.2016.05.002] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 13.2] [Reference Citation Analysis]
306 Bashir S, Sharma Y, Jairajpuri D, Rashid F, Nematullah M, Khan F. Alteration of adipose tissue immune cell milieu towards the suppression of inflammation in high fat diet fed mice by flaxseed oil supplementation. PLoS One 2019;14:e0223070. [PMID: 31622373 DOI: 10.1371/journal.pone.0223070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
307 Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontol 2000 2013;63:149-64. [PMID: 23931059 DOI: 10.1111/prd.12034] [Cited by in Crossref: 169] [Cited by in F6Publishing: 153] [Article Influence: 24.1] [Reference Citation Analysis]
308 Carlson SJ, Fallon EM, Kalish BT, Gura KM, Puder M. The Role of the ω-3 Fatty Acid DHA in the Human Life Cycle. JPEN J Parenter Enteral Nutr 2013;37:15-22. [DOI: 10.1177/0148607112467821] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
309 Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol. 2009;158:960-971. [PMID: 19594757 DOI: 10.1111/j.1476-5381.2009.00290.x] [Cited by in Crossref: 176] [Cited by in F6Publishing: 167] [Article Influence: 13.5] [Reference Citation Analysis]
310 Wéra O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. J Clin Med 2016;5:E118. [PMID: 27999328 DOI: 10.3390/jcm5120118] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 16.8] [Reference Citation Analysis]
311 Verduci E, D'Auria E, Bosetti A, DI Profio E, Vizzuso S, Milanta C, Pendezza E, Borsani B, Zuccotti GV. Immunomodulatory diet in pediatric age. Minerva Pediatr (Torino) 2021;73:128-49. [PMID: 33880904 DOI: 10.23736/S2724-5276.21.06214-9] [Reference Citation Analysis]
312 Calder PC. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake. Biochimie 2020;178:105-23. [PMID: 32860894 DOI: 10.1016/j.biochi.2020.08.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
313 Dangi B, Obeng M, Nauroth JM, Teymourlouei M, Needham M, Raman K, Arterburn LM. Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6). J Biol Chem 2009;284:14744-59. [PMID: 19324874 DOI: 10.1074/jbc.M809014200] [Cited by in Crossref: 53] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
314 Günay S, Taşova F, Yılmaz HE, Paköz ZB, Çekiç C. Serum Resolvin E1 Levels and Its Relationship with Disease Activity in Ulcerative Colitis. Gastroenterol Res Pract 2019;2019:6258327. [PMID: 30906319 DOI: 10.1155/2019/6258327] [Reference Citation Analysis]
315 Neurath MF, Leppkes M. Resolution of ulcerative colitis. Semin Immunopathol 2019;41:747-56. [DOI: 10.1007/s00281-019-00751-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
316 Bohr S, Patel SJ, Sarin D, Irimia D, Yarmush ML, Berthiaume F. Resolvin D2 prevents secondary thrombosis and necrosis in a mouse burn wound model. Wound Repair Regen 2013;21:35-43. [PMID: 23110665 DOI: 10.1111/j.1524-475X.2012.00853.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 49] [Article Influence: 7.2] [Reference Citation Analysis]
317 Yoshimura T, Oppenheim JJ. Chemerin reveals its chimeric nature. J Exp Med. 2008;205:2187-2190. [PMID: 18809717 DOI: 10.1084/jem.20081736] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
318 Saric J. Interactions between immunity and metabolism - contributions from the metabolic profiling of parasite-rodent models. Parasitology 2010;137:1451-66. [PMID: 20602847 DOI: 10.1017/S0031182010000697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
319 Calder PC. n -3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc 2013;72:326-36. [DOI: 10.1017/s0029665113001031] [Cited by in Crossref: 219] [Cited by in F6Publishing: 90] [Article Influence: 24.3] [Reference Citation Analysis]
320 Herrera BS, Ohira T, Gao L, Omori K, Yang R, Zhu M, Muscara MN, Serhan CN, Van Dyke TE, Gyurko R. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol 2008;155:1214-23. [PMID: 18806821 DOI: 10.1038/bjp.2008.367] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
321 Fredman G, Serhan CN. Specialized pro-resolving mediators: wiring the circuitry of effector immune and tissue homeostasis: Specialized pro-resolving mediators: wiring the circuitry of effector immune and tissue homeostasis. Endod Topics 2011;24:39-58. [DOI: 10.1111/etp.12010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
322 Sawada Y, Honda T, Nakamizo S, Otsuka A, Ogawa N, Kobayashi Y, Nakamura M, Kabashima K. Resolvin E1 attenuates murine psoriatic dermatitis. Sci Rep 2018;8:11873. [PMID: 30089836 DOI: 10.1038/s41598-018-30373-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
323 Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6:1191-1197. [PMID: 16369558 DOI: 10.1038/ni1276] [Cited by in Crossref: 1500] [Cited by in F6Publishing: 1401] [Article Influence: 93.8] [Reference Citation Analysis]
324 Siddiquee A, Patel M, Rajalingam S, Narke D, Kurade M, Ponnoth DS. Effect of omega-3 fatty acid supplementation on resolvin (RvE1)-mediated suppression of inflammation in a mouse model of asthma. Immunopharmacol Immunotoxicol 2019;41:250-7. [PMID: 30849257 DOI: 10.1080/08923973.2019.1584903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
325 Steinbach EC, Plevy SE. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis. 2014;20:166-175. [PMID: 23974993 DOI: 10.1097/mib.0b013e3182a69dca] [Cited by in Crossref: 123] [Cited by in F6Publishing: 77] [Article Influence: 15.4] [Reference Citation Analysis]
326 Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, Domschke W. Recent understanding of IBD pathogenesis: Implications for future therapies: . Inflammatory Bowel Diseases 2006;12:1068-83. [DOI: 10.1097/01.mib.0000235827.21778.d5] [Cited by in Crossref: 161] [Cited by in F6Publishing: 158] [Article Influence: 10.1] [Reference Citation Analysis]
327 Arnardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol 2016;9:757-66. [PMID: 26462421 DOI: 10.1038/mi.2015.99] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
328 Escobar A, Pérez M, Romanelli G, Blustein G. Thymol bioactivity: A review focusing on practical applications. Arabian Journal of Chemistry 2020;13:9243-69. [DOI: 10.1016/j.arabjc.2020.11.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
329 Liu M, Saeki K, Matsunobu T, Okuno T, Koga T, Sugimoto Y, Yokoyama C, Nakamizo S, Kabashima K, Narumiya S, Shimizu T, Yokomizo T. 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J Exp Med 2014;211:1063-78. [PMID: 24821912 DOI: 10.1084/jem.20132063] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 9.5] [Reference Citation Analysis]
330 Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis 2013;12:89. [PMID: 23767972 DOI: 10.1186/1476-511X-12-89] [Cited by in Crossref: 91] [Cited by in F6Publishing: 53] [Article Influence: 10.1] [Reference Citation Analysis]
331 Colombo JS, Moore AN, Hartgerink JD, D'Souza RN. Scaffolds to control inflammation and facilitate dental pulp regeneration. J Endod 2014;40:S6-12. [PMID: 24698696 DOI: 10.1016/j.joen.2014.01.019] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
332 Eisen DP, Moore EM, Leder K, Lockery J, McBryde ES, McNeil JJ, Pilcher D, Wolfe R, Woods RL. AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol. BMJ Open 2017;7:e013636. [PMID: 28110287 DOI: 10.1136/bmjopen-2016-013636] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
333 Yoon JY. Nutritional approach as therapeutic manipulation in inflammatory bowel disease. Intest Res 2019;17:463-75. [PMID: 31665832 DOI: 10.5217/ir.2019.00078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
334 He J, Bazan HE. Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot Essent Fatty Acids 2010;82:319-25. [PMID: 20202804 DOI: 10.1016/j.plefa.2010.02.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
335 Ahluwalia K, Ebright B, Chow K, Dave P, Mead A, Poblete R, Louie SG, Asante I. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development. Metabolites 2022;12:333. [DOI: 10.3390/metabo12040333] [Reference Citation Analysis]
336 Rinaldi SF, Hutchinson JL, Rossi AG, Norman JE. Anti-inflammatory mediators as physiological and pharmacological regulators of parturition. Expert Review of Clinical Immunology 2014;7:675-96. [DOI: 10.1586/eci.11.58] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
337 Prevete N, Liotti F, Amoresano A, Pucci P, de Paulis A, Melillo RM. New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution. Pharmacological Research 2018;128:80-7. [DOI: 10.1016/j.phrs.2017.09.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
338 Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Lochhead P, Richter JM, Chan AT. Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study. Inflamm Bowel Dis. 2017;23:1898-1904. [PMID: 28991856 DOI: 10.1097/mib.0000000000001236] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
339 Kobayashi Y, Ohfuji S, Kondo K, Fukushima W, Sasaki S, Kamata N, Yamagami H, Fujiwara Y, Suzuki Y, Hirota Y; Japanese Case-Control Study Group for Ulcerative Colitis. Association of Dietary Fatty Acid Intake With the Development of Ulcerative Colitis: A Multicenter Case-Control Study in Japan. Inflamm Bowel Dis 2021;27:617-28. [PMID: 32507894 DOI: 10.1093/ibd/izaa140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Van Dyke TE. Pro-resolving mediators in the regulation of periodontal disease. Mol Aspects Med 2017;58:21-36. [PMID: 28483532 DOI: 10.1016/j.mam.2017.04.006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 11.6] [Reference Citation Analysis]
341 Jung SH, Saxena A, Kaur K, Fletcher E, Ponemone V, Nottingham JM, Sheppe JA, Petroni M, Greene J, Graves K, Baliga MS, Fayad R. The role of adipose tissue-associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease. Cytokine 2013;61:459-68. [PMID: 23245845 DOI: 10.1016/j.cyto.2012.11.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
342 Nagaishi T, Chen Z, Chen L, Iijima H, Nakajima A, Blumberg RS. CEACAM1 and the regulation of mucosal inflammation. Mucosal Immunol 2008;1 Suppl 1:S39-42. [PMID: 19079227 DOI: 10.1038/mi.2008.50] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
343 Riella K, Marinho R, Santos J, Pereira-filho R, Cardoso J, Albuquerque-junior R, Thomazzi S. Anti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from Lippia gracilis, in rodents. Journal of Ethnopharmacology 2012;143:656-63. [DOI: 10.1016/j.jep.2012.07.028] [Cited by in Crossref: 122] [Cited by in F6Publishing: 107] [Article Influence: 12.2] [Reference Citation Analysis]
344 Knight SC. Specialized perinodal fat fuels and fashions immunity. Immunity 2008;28:135-8. [PMID: 18275823 DOI: 10.1016/j.immuni.2008.01.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
345 Reilly C. Neurogenic Inflammation: TRP Ion Channels in the Lung. Comprehensive Toxicology. Elsevier; 2010. pp. 129-49. [DOI: 10.1016/b978-0-08-046884-6.00929-5] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
346 Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment? Int J Mol Sci 2020;21:E5783. [PMID: 32806612 DOI: 10.3390/ijms21165783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
347 Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J 2006;20:401-3. [PMID: 16373400 DOI: 10.1096/fj.05-4724fje] [Cited by in Crossref: 276] [Cited by in F6Publishing: 256] [Article Influence: 16.2] [Reference Citation Analysis]
348 Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan SP, Petasis NA. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 2006;176:1848-59. [PMID: 16424216 DOI: 10.4049/jimmunol.176.3.1848] [Cited by in Crossref: 318] [Cited by in F6Publishing: 297] [Article Influence: 19.9] [Reference Citation Analysis]
349 Brennan EP, Cacace A, Godson C. Specialized pro-resolving mediators in renal fibrosis. Mol Aspects Med 2017;58:102-13. [PMID: 28479307 DOI: 10.1016/j.mam.2017.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
350 Deeken CR, Faucher KM, Matthews BD. A review of the composition, characteristics, and effectiveness of barrier mesh prostheses utilized for laparoscopic ventral hernia repair. Surg Endosc. 2012;26:566-575. [PMID: 21898010 DOI: 10.1007/s00464-011-1899-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
351 Balta MG, Loos BG, Nicu EA. Emerging Concepts in the Resolution of Periodontal Inflammation: A Role for Resolvin E1. Front Immunol 2017;8:1682. [PMID: 29312286 DOI: 10.3389/fimmu.2017.01682] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
352 Mao F, Wang M, Wang J, Xu W. The role of 15-LOX-1 in colitis and colitis-associated colorectal cancer. Inflamm Res 2015;64:661-9. [DOI: 10.1007/s00011-015-0852-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
353 Yaribeygi H, Atkin SL, Simental-Mendía LE, Barreto GE, Sahebkar A. Anti-inflammatory effects of resolvins in diabetic nephropathy: Mechanistic pathways. J Cell Physiol 2019. [PMID: 30746696 DOI: 10.1002/jcp.28315] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
354 Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids. 2005;73:141-162. [PMID: 16005201 DOI: 10.1016/j.plefa.2005.05.002] [Cited by in Crossref: 285] [Cited by in F6Publishing: 278] [Article Influence: 17.8] [Reference Citation Analysis]
355 Ishida T, Yoshida M, Arita M, Nishitani Y, Nishiumi S, Masuda A, Mizuno S, Takagawa T, Morita Y, Kutsumi H, Inokuchi H, Serhan CN, Blumberg RS, Azuma T. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis. Inflamm Bowel Dis 2010;16:87-95. [PMID: 19572372 DOI: 10.1002/ibd.21029] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 9.3] [Reference Citation Analysis]
356 Rohwer N, Chiu CY, Huang D, Smyl C, Rothe M, Rund KM, Helge Schebb N, Kühn H, Weylandt KH. Omega-3 fatty acids protect from colitis via an Alox15-derived eicosanoid. FASEB J 2021;35:e21491. [PMID: 33710695 DOI: 10.1096/fj.202002340RR] [Reference Citation Analysis]
357 Kuzumoto T, Tanigawa T, Higashimori A, Kitamura H, Nadatani Y, Otani K, Fukunaga S, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Watanabe T, Fujiwara Y. Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damage. PLoS One 2021;16:e0250862. [PMID: 33945545 DOI: 10.1371/journal.pone.0250862] [Reference Citation Analysis]
358 Weylandt KH, Kang JX, Wiedenmann B, Baumgart DC. Lipoxins and resolvins in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:797-799. [PMID: 17262807 DOI: 10.1002/ibd.20109] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
359 Köhnke T, Gomolka B, Bilal S, Zhou X, Sun Y, Rothe M, Baumgart DC, Weylandt KH. Acetylsalicylic Acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators. Biomed Res Int. 2013;2013:748160. [PMID: 24083240 DOI: 10.1155/2013/748160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
360 Hsiao H, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, Olsen KC, Pollock SJ, Serhan CN, Phipps RP, Sime PJ, Yildirim AÖ. A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation. PLoS ONE 2013;8:e58258. [DOI: 10.1371/journal.pone.0058258] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 13.4] [Reference Citation Analysis]
361 Momotani E, Ozaki H, Hori M, Yamamoto S, Kuribayashi T, Eda S, Ikegami M. Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn's disease-type necrotizing colitis in Mice. Springerplus 2012;1:47. [PMID: 23519342 DOI: 10.1186/2193-1801-1-47] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
362 Deering-rice C, Reilly C. Neurogenic Inflammation: TRP Ion Channels in the Lung. Comprehensive Toxicology. Elsevier; 2018. pp. 302-21. [DOI: 10.1016/b978-0-12-801238-3.99193-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
363 González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, Martínez-Clemente M, López-Parra M, Arroyo V, Clària J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 2009;23:1946-57. [PMID: 19211925 DOI: 10.1096/fj.08-125674] [Cited by in Crossref: 394] [Cited by in F6Publishing: 373] [Article Influence: 30.3] [Reference Citation Analysis]
364 Ramon S, Bancos S, Serhan CN, Phipps RP. Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism. Eur J Immunol 2014;44:357-69. [PMID: 24166736 DOI: 10.1002/eji.201343316] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
365 Deckelbaum RJ, Akabas SR. n−3 Fatty acids and cardiovascular disease: navigating toward recommendations. The American Journal of Clinical Nutrition 2006;84:1-2. [DOI: 10.1093/ajcn/84.1.1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
366 Kalish BT, Fallon EM, Puder M. A tutorial on fatty acid biology. JPEN J Parenter Enteral Nutr 2012;36:380-8. [PMID: 22635607 DOI: 10.1177/0148607112449650] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
367 Levy BD. Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways. Front Immunol 2012;3:390. [PMID: 23293638 DOI: 10.3389/fimmu.2012.00390] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
368 Morshedzadeh N, Saedisomeolia A, Djalali M, Eshraghian MR, Hantoushzadeh S, Mahmoudi M. Resolvin D1 impacts on insulin resistance in women with polycystic ovary syndrome and healthy women. Diabetes Metab Syndr 2019;13:660-4. [PMID: 30641785 DOI: 10.1016/j.dsx.2018.11.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
369 Halade GV, Black LM, Verma MK. Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery. Biotechnol Adv 2018;36:935-53. [PMID: 29499340 DOI: 10.1016/j.biotechadv.2018.02.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
370 Hung ND, Kim MR, Sok DE. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis. Br J Pharmacol 2011;162:1119-35. [PMID: 21091644 DOI: 10.1111/j.1476-5381.2010.01117.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
371 Obrosov A, Coppey LJ, Shevalye H, Yorek MA. Effect of Fish Oil vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy. J Neurol Neurophysiol 2017;8:453. [PMID: 29423332 DOI: 10.4172/2155-9562.1000453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
372 Qu X, Zhang X, Yao J, Song J, Nikolic-Paterson DJ, Li J. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J Pathol 2012;228:506-19. [PMID: 22610993 DOI: 10.1002/path.4050] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
373 Feng G, Chen J, Lin C, Yang J. Effect of docosahexaenoic acid on hypoxia/reoxygenation injury in human coronary arterial smooth muscle cells. Eur J Nutr 2012;51:987-95. [DOI: 10.1007/s00394-011-0278-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
374 Pierce RA, Perrone JM, Nimeri A, Sexton JA, Walcutt J, Frisella MM, Matthews BD. 120-Day Comparative Analysis of Adhesion Grade and Quantity, Mesh Contraction, and Tissue Response to a Novel Omega-3 Fatty Acid Bioabsorbable Barrier Macroporous Mesh After Intraperitoneal Placement. Surg Innov 2009;16:46-54. [DOI: 10.1177/1553350608330479] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
375 Bosco N, Brahmbhatt V, Oliveira M, Martin FP, Lichti P, Raymond F, Mansourian R, Metairon S, Pace-Asciak C, Bastic Schmid V, Rezzi S, Haller D, Benyacoub J. Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis. Lipids Health Dis 2013;12:81. [PMID: 23725086 DOI: 10.1186/1476-511X-12-81] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
376 Tian R, Zuo X, Jaoude J, Mao F, Colby J, Shureiqi I. ALOX15 as a suppressor of inflammation and cancer: Lost in the link. Prostaglandins Other Lipid Mediat 2017;132:77-83. [PMID: 28089732 DOI: 10.1016/j.prostaglandins.2017.01.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
377 Abeles AM, Pillinger MH, Abramson SB. Inflammation. Rheumatology. Elsevier; 2011. pp. 183-198.e2. [DOI: 10.1016/b978-0-323-06551-1.00021-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
378 Sundaram TS, Giromini C, Rebucci R, Pistl J, Bhide M, Baldi A. Role of omega-3 polyunsaturated fatty acids, citrus pectin, and milk-derived exosomes on intestinal barrier integrity and immunity in animals. J Animal Sci Biotechnol 2022;13. [DOI: 10.1186/s40104-022-00690-7] [Reference Citation Analysis]
379 Herrera BS, Hasturk H, Kantarci A, Freire MO, Nguyen O, Kansal S, Van Dyke TE. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Infect Immun. 2015;83:792-801. [PMID: 25486994 DOI: 10.1128/iai.02444-14] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 6.9] [Reference Citation Analysis]
380 Chiang N, Serhan CN. New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications. Compr Ther 2006;32:150-7. [PMID: 17435267 DOI: 10.1007/s12019-006-0005-6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
381 Clària J, González-Périz A, López-Vicario C, Rius B, Titos E. New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators. Front Immunol 2011;2:49. [PMID: 22566839 DOI: 10.3389/fimmu.2011.00049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
382 Jinno Y, Nakakuki M, Sato A, Kawano H, Notsu T, Mizuguchi K, Shimano H. Cide-a and Cide-c are induced in the progression of hepatic steatosis and inhibited by eicosapentaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2010;83:75-81. [PMID: 20542418 DOI: 10.1016/j.plefa.2010.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
383 Snyder NW, Golin-Bisello F, Gao Y, Blair IA, Freeman BA, Wendell SG. 15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways. Chem Biol Interact 2015;234:144-53. [PMID: 25450232 DOI: 10.1016/j.cbi.2014.10.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
384 Gadaria-Rathod N, Lee KI, Asbell PA. Emerging drugs for the treatment of dry eye disease. Expert Opin Emerg Drugs 2013;18:121-36. [PMID: 23621500 DOI: 10.1517/14728214.2013.791676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
385 Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of Inflammation: What Controls Its Onset? Front Immunol 2016;7:160. [PMID: 27199985 DOI: 10.3389/fimmu.2016.00160] [Cited by in Crossref: 214] [Cited by in F6Publishing: 213] [Article Influence: 35.7] [Reference Citation Analysis]
386 Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions 2017;45:1105-15. [DOI: 10.1042/bst20160474] [Cited by in Crossref: 366] [Cited by in F6Publishing: 192] [Article Influence: 73.2] [Reference Citation Analysis]
387 Serhan CN, Lu Y, Hong S, Yang R. Mediator Lipidomics: Search Algorithms for Eicosanoids, Resolvins, and Protectins. Lipidomics and Bioactive Lipids: Mass‐Spectrometry–Based Lipid Analysis. Elsevier; 2007. pp. 275-317. [DOI: 10.1016/s0076-6879(07)32012-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
388 N. Serhan C, Krishnamoorthy S, Recchiuti A, Chiang N. . CTMC 2011;11:629-47. [DOI: 10.2174/1568026611109060629] [Cited by in Crossref: 188] [Cited by in F6Publishing: 171] [Article Influence: 17.1] [Reference Citation Analysis]
389 Qu L, Caterina MJ. Accelerating the reversal of inflammatory pain with NPD1 and its receptor GPR37. J Clin Invest 2018;128:3246-9. [PMID: 30010628 DOI: 10.1172/JCI122203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
390 Lu Y, Hong S, Yang R, Uddin J, Gotlinger KH, Petasis NA, Serhan CN. Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low-energy tandem mass spectrometry: spectra and fragmentation mechanisms. Rapid Commun Mass Spectrom 2007;21:7-22. [PMID: 17131464 DOI: 10.1002/rcm.2798] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
391 Börgeson E, Godson C. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front Immunol 2012;3:318. [PMID: 23087692 DOI: 10.3389/fimmu.2012.00318] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
392 Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, Ailawadi G, Upchurch GR Jr. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. FASEB J 2016;30:4192-201. [PMID: 27619672 DOI: 10.1096/fj.201600144RR] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
393 Rodriguez-leyva D, Malik A, Tappia PS. Gender-related gene expression in response to dietary fatty acids and predisposition to atherosclerosis and cardiovascular disease. Clinical Lipidology 2011;6:653-64. [DOI: 10.2217/clp.11.62] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
394 Gudernatsch V, Stefańczyk SA, Mirakaj V. Novel Resolution Mediators of Severe Systemic Inflammation. Immunotargets Ther 2020;9:31-41. [PMID: 32185148 DOI: 10.2147/ITT.S243238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
395 Maheshwari RA, Balaraman R, Sailor GU, Sen DB. Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats. Indian J Pharmacol. 2015;47:17-21. [PMID: 25821305 DOI: 10.4103/0253-7613.150311] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
396 Serhan CN. Controlling the Resolution of Acute Inflammation: A New Genus of Dual Anti-Inflammatory and Proresolving Mediators. Journal of Periodontology 2008;79:1520-6. [DOI: 10.1902/jop.2008.080231] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
397 Corazza BJM, Martinho FC, Khoury RD, Toia CC, Orozco EIF, Prado RF, Machado FP, Valera MC. Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis. Int Endod J 2021;54:61-73. [PMID: 32896000 DOI: 10.1111/iej.13403] [Reference Citation Analysis]
398 López-Vicario C, Rius B, Alcaraz-Quiles J, González-Périz A, Martínez-Puchol AI, Casulleras M, Duran-Güell M, Ibarzabal A, Corcelles R, Laguna-Fernández A, Back M, Titos E, Clària J. Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals. Sci Rep 2017;7:15724. [PMID: 29146976 DOI: 10.1038/s41598-017-15951-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
399 Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, Mizuguchi K, Itoh M, Suganami T, Ogawa Y. Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 2010;59:2495-504. [PMID: 20682690 DOI: 10.2337/db09-1554] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 9.3] [Reference Citation Analysis]
400 Herrera BS, Kantarci A, Zarrough A, Hasturk H, Leung KP, Van Dyke TE. LXA4 actions direct fibroblast function and wound closure. Biochem Biophys Res Commun 2015;464:1072-7. [PMID: 26188508 DOI: 10.1016/j.bbrc.2015.07.076] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
401 de Jonge WJ, Greaves DR. Immune modulation in gastrointestinal disorders: new opportunities for therapeutic peptides? Expert Rev Gastroenterol Hepatol 2008;2:741-8. [PMID: 19090735 DOI: 10.1586/17474124.2.6.741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
402 Feng C, Li L, Li Q, Switzer K, Liu M, Han S, Zheng B. Docosahexaenoic acid ameliorates autoimmune inflammation by activating GPR120 signaling pathway in dendritic cells. Int Immunopharmacol 2021;97:107698. [PMID: 33932699 DOI: 10.1016/j.intimp.2021.107698] [Reference Citation Analysis]
403 Calder PC, Albers R, Antoine J, Blum S, Bourdet-sicard R, Ferns GA, Folkerts G, Friedmann PS, Frost GS, Guarner F, Løvik M, Macfarlane S, Meyer PD, M'rabet L, Serafini M, van Eden W, van Loo J, Vas Dias W, Vidry S, Winklhofer-roob BM, Zhao J. Inflammatory Disease Processes and Interactions with Nutrition. Br J Nutr 2009;101:1-45. [DOI: 10.1017/s0007114509377867] [Cited by in Crossref: 186] [Cited by in F6Publishing: 102] [Article Influence: 14.3] [Reference Citation Analysis]
404 Trauer J, Muhi S, McBryde ES, Al Harbi SA, Arabi YM, Boyle AJ, Cartin-Ceba R, Chen W, Chen YT, Falcone M, Gajic O, Godsell J, Gong MN, Kor D, Lösche W, McAuley DF, O'Neal HR Jr, Osthoff M, Otto GP, Sossdorf M, Tsai MJ, Valerio-Rojas JC, van der Poll T, Violi F, Ware L, Widmer AF, Wiewel MA, Winning J, Eisen DP. Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching. Crit Care Med 2017;45:1871-9. [PMID: 28799949 DOI: 10.1097/CCM.0000000000002654] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 4.2] [Reference Citation Analysis]
405 Murck H, Manku M. Ethyl-EPA in Huntington disease: potentially relevant mechanism of action. Brain Res Bull 2007;72:159-64. [PMID: 17352940 DOI: 10.1016/j.brainresbull.2006.10.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
406 Uchi SH, Yanai R, Kobayashi M, Hatano M, Kobayashi Y, Yamashiro C, Nagai T, Tokuda K, Connor KM, Sonoda KH, Kimura K. Dendritic cells mediate the anti-inflammatory action of omega-3 long-chain polyunsaturated fatty acids in experimental autoimmune uveitis. PLoS One 2019;14:e0219405. [PMID: 31335861 DOI: 10.1371/journal.pone.0219405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
407 Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 2018;128:2657-69. [PMID: 29757195 DOI: 10.1172/JCI97943] [Cited by in Crossref: 410] [Cited by in F6Publishing: 250] [Article Influence: 102.5] [Reference Citation Analysis]
408 Clària J, Horrillo R, Martínez-Clemente M, Morán-Salvador E, Titos E, González-Périz A, Ferré N. [Basic mechanisms of hepatocellular injury. Role of inflammatory lipid mediators]. Gastroenterol Hepatol 2008;31:682-92. [PMID: 19174085 DOI: 10.1016/S0210-5705(08)75816-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
409 Bezerra B, Monajemzadeh S, Silva D, Pirih FQ. Modulating the Immune Response in Periodontitis. Front Dent Med 2022;3:879131. [DOI: 10.3389/fdmed.2022.879131] [Reference Citation Analysis]
410 Bruins MJ, Dane AD, Strassburg K, Vreeken RJ, Newman JW, Salem N Jr, Tyburczy C, Brenna JT. Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets. J Lipid Res 2013;54:1598-607. [PMID: 23543770 DOI: 10.1194/jlr.M034918] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
411 Rodriguez-Echevarria R, Macias-Barragan J, Parra-Vargas M, Davila-Rodriguez JR, Amezcua-Galvez E, Armendariz-Borunda J. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice. World J Gastroenterol 2018; 24(4): 461-474 [PMID: 29398867 DOI: 10.3748/wjg.v24.i4.461] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]